Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionhistone H3K4 methyltransferase activity

KMT2B KMT2C SETMAR PRDM7

7.68e-05202344GO:0042800
GeneOntologyMolecularFunctionguanyl-nucleotide exchange factor activity

PSD OBSCN ARHGEF16 SBF1 FGD5 HERC1 DNMBP ARHGEF10L ARHGEF10 ARHGEF2 PLCE1

9.31e-0523123411GO:0005085
GeneOntologyMolecularFunctionhistone H3 methyltransferase activity

KMT2B KMT2C SETMAR NSD2 PRDM7

1.58e-04442345GO:0140938
GeneOntologyMolecularFunctionhistone methyltransferase activity

EED KMT2B KMT2C SETMAR NSD2 PRDM7

1.84e-04712346GO:0042054
GeneOntologyMolecularFunctionnucleoside-triphosphatase regulator activity

PSD MYO9B OBSCN GMIP ARHGEF16 SBF1 FGD5 HERC1 DNMBP RASA2 GPS1 RGS12 ARHGEF10L ARHGEF10 ARHGEF2 PLCE1

3.36e-0450723416GO:0060589
GeneOntologyMolecularFunctionGTPase regulator activity

PSD MYO9B OBSCN GMIP ARHGEF16 SBF1 FGD5 HERC1 DNMBP RASA2 GPS1 RGS12 ARHGEF10L ARHGEF10 ARHGEF2 PLCE1

3.36e-0450723416GO:0030695
GeneOntologyMolecularFunctionphosphatase regulator activity

PPP1R12A PPP1R2B SBF1 PPP1R1B PPP1R2P1 PPP1R2 PPP1R12C

3.74e-041132347GO:0019208
GeneOntologyMolecularFunctionhistone H3K36 methyltransferase activity

SETMAR NSD2 PRDM7

4.17e-04132343GO:0046975
GeneOntologyMolecularFunctionphosphatase inhibitor activity

PPP1R2B SBF1 PPP1R1B PPP1R2P1 PPP1R2

4.20e-04542345GO:0019212
GeneOntologyMolecularFunctionhistone H3K36 dimethyltransferase activity

SETMAR NSD2

8.08e-0442342GO:0140954
GeneOntologyMolecularFunctionATP-dependent chromatin remodeler activity

ERCC6L SMARCAD1 INO80 SMARCA4

8.96e-04372344GO:0140658
GeneOntologyMolecularFunctionprotein-lysine N-methyltransferase activity

KMT2B KMT2C SETMAR NSD2 PRDM7

1.21e-03682345GO:0016279
GeneOntologyMolecularFunctionprotein serine kinase activity

GAK OBSCN CDK11A MAP3K12 NEK1 TAF1 MAP4K4 WNK2 SIK3 MAP3K6 MAP3K13 SBK3

1.25e-0336323412GO:0106310
GeneOntologyMolecularFunctionlysine N-methyltransferase activity

KMT2B KMT2C SETMAR NSD2 PRDM7

1.29e-03692345GO:0016278
GeneOntologyMolecularFunctionprotein methyltransferase activity

EED KMT2B KMT2C SETMAR NSD2 PRDM7

1.35e-031032346GO:0008276
GeneOntologyBiologicalProcessheart development

RBM10 RB1CC1 LUZP1 MET SCN5A ARL13B CACNA1G FGFR1 DNAH5 HECTD1 SIN3B ANK2 ADAMTS1 NSD2 DUSP6 KAT6A LEMD2 FHOD3 IRX3 ZBTB14 VANGL2 CTCF CTDP1 SNAI2 SMARCA4

1.33e-0675723025GO:0007507
GeneOntologyBiologicalProcessmembrane depolarization during SA node cell action potential

SCN5A CACNA1G ANK2

1.35e-0552303GO:0086046
GeneOntologyBiologicalProcessestablishment of cell polarity

MAP1B MYO9B CLASP2 PARD6A KCNQ2 WEE1 CAMSAP3 VANGL2 ARHGEF2 PHLDB2

3.10e-0517723010GO:0030010
GeneOntologyBiologicalProcessestablishment or maintenance of cell polarity

MAP1B MYO9B CLASP2 PARD6A KCNQ2 DLG2 ATN1 WEE1 CAMSAP3 VANGL2 ARHGEF2 PHLDB2

3.36e-0525723012GO:0007163
GeneOntologyBiologicalProcessribosomal large subunit export from nucleus

RBM10 SDAD1 NMD3

7.35e-0582303GO:0000055
GeneOntologyBiologicalProcessGolgi organization

GAK CLASP2 AP5Z1 GOLGA8T CAMSAP3 GOLGA8R TRAPPC12 PDE4DIP SEC23IP

1.16e-041682309GO:0007030
GeneOntologyBiologicalProcessprotein localization to M-band

OBSCN ANK2

1.24e-0422302GO:0036309
GeneOntologyBiologicalProcessmicrotubule-based process

MAP1B KIZ PPP1R12A CDK11A CLASP2 LYST DNAAF8 MET PARD6A DLG2 DNAH5 TXNDC2 DNHD1 COPG1 WEE1 CAMSAP3 DYNC2I1 INO80 SIK3 CELSR2 ARHGEF10 PDE4DIP SENP6 ARHGEF2 STAG2 PHLDB2

1.37e-04105823026GO:0007017
GeneOntologyBiologicalProcessprotein-DNA complex organization

BRPF3 EED KMT2B ERCC6L SMARCAD1 TRIP12 KMT2C TONSL TAF1 TADA3 SETMAR L3MBTL2 ARID4A NSD2 KAT6A INO80 PRDM7 IWS1 SLF2 CTCF TRAPPC12 SNAI2 SMARCA4 SENP6 PAX7

1.40e-0499923025GO:0071824
GeneOntologyBiologicalProcessSA node cell to atrial cardiac muscle cell signaling

SCN5A CACNA1G ANK2

1.55e-04102303GO:0086018
GeneOntologyBiologicalProcessSA node cell action potential

SCN5A CACNA1G ANK2

1.55e-04102303GO:0086015
GeneOntologyBiologicalProcessregulation of phosphatase activity

PPP1R12A CMYA5 PPP1R2B PPP1R1B PPP1R2P1 PPP1R2

1.77e-04742306GO:0010921
GeneOntologyBiologicalProcesschromatin organization

BRPF3 EED KMT2B ERCC6L SMARCAD1 TRIP12 KMT2C TONSL TAF1 TADA3 SETMAR L3MBTL2 ARID4A NSD2 KAT6A INO80 PRDM7 IWS1 SLF2 CTCF SNAI2 SMARCA4 PAX7

1.81e-0489623023GO:0006325
GeneOntologyBiologicalProcessendomembrane system organization

GAK LEMD3 CLASP2 RILP LYST RTN1 AP5Z1 CAVIN2 DOC2B ANO4 GOLGA8T ANK2 RETREG2 LEMD2 CAMSAP3 GOLGA8R TRAPPC12 PDE4DIP SEC23IP

2.03e-0467223019GO:0010256
GeneOntologyBiologicalProcessregulation of branching involved in salivary gland morphogenesis

MET FGFR1 SNAI2

2.11e-04112303GO:0060693
GeneOntologyBiologicalProcessSA node cell to atrial cardiac muscle cell communication

SCN5A CACNA1G ANK2

2.11e-04112303GO:0086070
GeneOntologyCellularComponentcytoplasmic microtubule plus-end

CLASP2 PDE4DIP

1.26e-0422352GO:1904511
GeneOntologyCellularComponentcortical microtubule plus-end

CLASP2 PDE4DIP

1.26e-0422352GO:1903754
GeneOntologyCellularComponentnuclear chromosome

SYCP2L ERCC5 SMARCAD1 SAP30 TONSL SIN3B ARID4A CAMSAP3 INO80 RGS12 SMARCA4

1.50e-0425423511GO:0000228
GeneOntologyCellularComponenthistone methyltransferase complex

EED KMT2B CXXC1 KMT2C BOD1L1 TAF1

2.00e-04752356GO:0035097
GeneOntologyCellularComponentcortical microtubule

CLASP2 PDE4DIP

3.75e-0432352GO:0055028
GeneOntologyCellularComponentnuclear speck

RBM10 CMYA5 TRIP12 CXXC1 NCBP3 RBM25 AP5Z1 HECTD1 POLR2D KAT6A ZC3H18 ZNF106 POLI ACIN1

3.96e-0443123514GO:0016607
DomainRhoGEF

OBSCN ARHGEF16 FGD5 DNMBP ARHGEF10L ARHGEF10 ARHGEF2

1.84e-05682277SM00325
DomainRhoGEF

OBSCN ARHGEF16 FGD5 DNMBP ARHGEF10L ARHGEF10 ARHGEF2

2.23e-05702277PF00621
DomainDH_2

OBSCN ARHGEF16 FGD5 DNMBP ARHGEF10L ARHGEF10 ARHGEF2

2.23e-05702277PS50010
Domain-

OBSCN ARHGEF16 FGD5 DNMBP ARHGEF10L ARHGEF10 ARHGEF2

2.45e-057122771.20.900.10
DomainDH-domain

OBSCN ARHGEF16 FGD5 DNMBP ARHGEF10L ARHGEF10 ARHGEF2

2.45e-05712277IPR000219
DomainPost-SET_dom

KMT2B KMT2C SETMAR NSD2

3.45e-05162274IPR003616
DomainPostSET

KMT2B KMT2C SETMAR NSD2

3.45e-05162274SM00508
DomainPOST_SET

KMT2B KMT2C SETMAR NSD2

3.45e-05162274PS50868
DomainPHD

BRPF3 KMT2B CXXC1 KMT2C NSD2 KAT6A PHRF1

3.51e-05752277PF00628
DomainZnf_PHD-finger

BRPF3 KMT2B CXXC1 KMT2C NSD2 KAT6A PHRF1

4.93e-05792277IPR019787
DomainPH_dom-like

PSD OBSCN ARHGEF16 LYST SBF1 FGD5 IRS4 RASA2 VEPH1 RGS12 ARHGEF10L ARHGEF10 ARHGEF2 EPB41L1 PHLDB2 PLCE1

6.95e-0542622716IPR011993
DomainZnf_FYVE_PHD

BRPF3 KMT2B CXXC1 KMT2C FGD5 MLPH NSD2 KAT6A PHRF1

7.96e-051472279IPR011011
DomainGDS_CDC24_CS

OBSCN ARHGEF16 DNMBP ARHGEF10 ARHGEF2

1.04e-04392275IPR001331
DomainPHD

BRPF3 KMT2B CXXC1 KMT2C NSD2 KAT6A PHRF1

1.06e-04892277SM00249
DomainDH_1

OBSCN ARHGEF16 DNMBP ARHGEF10L ARHGEF10 ARHGEF2

1.15e-04632276PS00741
DomainZnf_PHD

BRPF3 KMT2B CXXC1 KMT2C NSD2 KAT6A PHRF1

1.22e-04912277IPR001965
DomainMSC

LEMD3 LEMD2

1.47e-0422272PF09402
DomainMAP3K12_MAP3K13

MAP3K12 MAP3K13

1.47e-0422272IPR017419
DomainInner-Nucl-membr_MAN1

LEMD3 LEMD2

1.47e-0422272IPR018996
DomainZF_PHD_2

BRPF3 KMT2B CXXC1 KMT2C NSD2 KAT6A PHRF1

1.59e-04952277PS50016
DomainZF_PHD_1

BRPF3 KMT2B CXXC1 KMT2C NSD2 KAT6A PHRF1

1.70e-04962277PS01359
DomainSET

KMT2B KMT2C SETMAR NSD2 PRDM7

2.32e-04462275SM00317
DomainHECT

TRIP12 HERC1 HECTD1 ITCH

2.99e-04272274PF00632
DomainHECTc

TRIP12 HERC1 HECTD1 ITCH

2.99e-04272274SM00119
DomainHECT_dom

TRIP12 HERC1 HECTD1 ITCH

2.99e-04272274IPR000569
DomainHECT

TRIP12 HERC1 HECTD1 ITCH

2.99e-04272274PS50237
Domain-

PSD OBSCN ARHGEF16 SBF1 FGD5 IRS4 RASA2 VEPH1 RGS12 ARHGEF10L ARHGEF2 EPB41L1 PHLDB2 PLCE1

3.22e-04391227142.30.29.30
DomainSET_dom

KMT2B KMT2C SETMAR NSD2 PRDM7

3.44e-04502275IPR001214
DomainSET

KMT2B KMT2C SETMAR NSD2 PRDM7

3.44e-04502275PS50280
DomainPRKG1_interact

PPP1R12A PPP1R12C

4.38e-0432272IPR031775
DomainPRKG1_interact

PPP1R12A PPP1R12C

4.38e-0432272PF15898
DomainMYPT1/MYPT2_chordates

PPP1R12A PPP1R12C

4.38e-0432272IPR017401
DomainSNF2_N

ERCC6L SMARCAD1 INO80 SMARCA4

5.85e-04322274IPR000330
DomainSNF2_N

ERCC6L SMARCAD1 INO80 SMARCA4

5.85e-04322274PF00176
DomainCavin_fam

CAVIN2 CAVIN3

8.68e-0442272IPR026752
DomainPTRF_SDPR

CAVIN2 CAVIN3

8.68e-0442272PF15237
DomainARM-type_fold

CLASP2 TRIP12 LYST NOC4L HECTD1 COPG1 MROH2A VEPH1 USP24 FHOD3 SDAD1 STAG2

9.44e-0433922712IPR016024
DomainHomeobox_KN

MEIS3 IRX3 IRX2

1.06e-03172273PF05920
DomainHomeobox_KN_domain

MEIS3 IRX3 IRX2

1.06e-03172273IPR008422
DomainFYrich_C

KMT2B KMT2C

1.44e-0352272IPR003889
DomainFYrich_N

KMT2B KMT2C

1.44e-0352272IPR003888
DomainFYRC

KMT2B KMT2C

1.44e-0352272SM00542
DomainFYRN

KMT2B KMT2C

1.44e-0352272SM00541
DomainLEM

LEMD3 LEMD2

1.44e-0352272SM00540
DomainFYRN

KMT2B KMT2C

1.44e-0352272PF05964
DomainFYRC

KMT2B KMT2C

1.44e-0352272PF05965
DomainFYRC

KMT2B KMT2C

1.44e-0352272PS51543
DomainFYRN

KMT2B KMT2C

1.44e-0352272PS51542
DomainSer/Thr_kinase_AS

GAK OBSCN CDK11A MAP3K12 NEK1 MAP4K4 WNK2 WEE1 SIK3 MAP3K6 MAP3K13 SBK3

1.47e-0335722712IPR008271
DomainSET

KMT2B KMT2C SETMAR NSD2

1.51e-03412274PF00856
DomainPROTEIN_KINASE_ATP

GAK OBSCN CDK11A MAP3K12 MET NEK1 FGFR1 MAP4K4 WNK2 WEE1 SIK3 MAP3K6 MAP3K13 SBK3

1.53e-0345922714PS00107
DomainS_TKc

GAK OBSCN CDK11A MAP3K12 NEK1 MAP4K4 WNK2 WEE1 SIK3 MAP3K6 MAP3K13 SBK3

1.54e-0335922712SM00220
DomainPROTEIN_KINASE_ST

GAK OBSCN CDK11A MAP3K12 NEK1 MAP4K4 WNK2 WEE1 SIK3 MAP3K6 MAP3K13 SBK3

1.65e-0336222712PS00108
PathwayREACTOME_RHO_GTPASE_CYCLE

LEMD3 MYO9B OBSCN GMIP ARHGEF16 PARD6A ARL13B FGD5 DNMBP GOLGA3 HSP90AA1 GPS1 GOLGA8R AKAP12 ARHGEF10L VANGL2 ARHGEF10 FAM169A ARHGEF2

1.61e-0645016719M27078
PathwayREACTOME_RHO_GTPASE_CYCLE

MYO9B OBSCN GMIP ARHGEF16 PARD6A ARL13B FGD5 DNMBP GOLGA3 HSP90AA1 GPS1 AKAP12 ARHGEF10L VANGL2 ARHGEF10 FAM169A ARHGEF2

1.81e-0543916717MM15595
PathwayREACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3

ERCC6L LEMD3 MYO9B PPP1R12A OBSCN CLASP2 GMIP ARHGEF16 PARD6A ARL13B FGD5 DNMBP GOLGA3 HSP90AA1 GPS1 GOLGA8R AKAP12 ARHGEF10L VANGL2 ARHGEF10 FAM169A ARHGEF2

4.15e-0572016722M41838
PathwayREACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3

ERCC6L MYO9B PPP1R12A OBSCN CLASP2 GMIP ARHGEF16 PARD6A ARL13B FGD5 DNMBP GOLGA3 HSP90AA1 GPS1 AKAP12 ARHGEF10L VANGL2 ARHGEF10 FAM169A ARHGEF2

8.49e-0564916720MM15690
PathwayREACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES

KMT2B CXXC1 KMT2C BOD1L1 TADA3

1.31e-04421675M48018
PathwayPID_PLK1_PATHWAY

ERCC6L KIZ PPP1R12A WEE1 STAG2

2.03e-04461675M129
PathwayPID_RHOA_REG_PATHWAY

MYO9B OBSCN ARHGEF10L ARHGEF10 ARHGEF2

2.03e-04461675M68
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

ERCC5 KMT2B ERCC6L RBM10 CDK11A SMARCAD1 ZNF318 TRIP12 SAP30 RBM25 ZNF579 DNMBP DDX41 MAP4K4 ATN1 TCOF1 ARID4A WEE1 PHRF1 CAMSAP3 USP24 ZC3H18 STRIP1 IWS1 PPP1R2 ZNF106 NOL4L CTDP1 SMARCA4 SENP6 ACIN1 EIF3B ARHGEF2 SNAPC4 STAG2 PHLDB2

2.20e-197742423615302935
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

NES MAP1B ERCC6L PPP1R12A CLASP2 ARHGEF16 TRIP12 LYST LUZP1 NEK1 SBF1 BOD1L1 DNMBP DDX41 HECTD1 MAP4K4 IRS4 ITCH WEE1 CAMSAP3 SIK3 MAP3K6 SPECC1 RGS12 LPIN3 ZNF106 ARHGEF10 SLF2 CLMN SSH2 ARHGEF2 CEP170B EPB41L1 PHLDB2 PPP1R12C

4.73e-178612423536931259
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

KMT2B MYO9B PIEZO1 OBSCN CLASP2 WASHC2A LYST SAP30 KMT2C SBF1 SCN5A KCNQ2 FGFR1 ZNF579 HERC1 DNMBP HECTD1 WNK2 PICK1 B4GALNT4 NSD2 KAT6A INO80 ARHGEF10L RABL6 LPIN3 CELSR2 ADAMTS7 TRAPPC12 FURIN CTDP1 ARHGEF2 SNAPC4 IL4R CEP170B

8.06e-1411052423535748872
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

NES NHSL2 PPP1R12A CLASP2 ZNF318 ARMCX4 RTN1 LUZP1 SBF1 DLG2 MAP4K4 GOLGA3 WNK2 HSP90AA1 SIN3B ITCH ANK2 TCOF1 CAMSAP3 SIK3 AKAP12 STRIP1 CELSR2 CTCF PDE4DIP SEC23IP SMARCA4 SSH2 ARHGEF2 CEP170B EPB41L1 PHLDB2

2.91e-139632423228671696
Pubmed

Phosphoproteomic analysis of the developing mouse brain.

NES MAP1B CLASP2 GMIP PPP1R2B NEK1 PARD6A PPP1R2P1 MAP4K4 TCOF1 AKAP12 STRIP1 PPP1R2 CEP41 EIF3B SSH2 EPB41L1

2.06e-122462421715345747
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

EED ATXN7L2 KMT2B RRP1B LEMD3 RBM10 ZNF318 TRIP12 CXXC1 SAP30 KMT2C RBM25 BBX TONSL DDX41 TADA3 SIN3B L3MBTL2 TCOF1 ARID4A NSD2 POLR2D LEMD2 PHRF1 ZC3H18 INO80 CPT1A ZBTB14 IWS1 ZNF106 SLF2 CTCF SMARCA4 ACIN1 STAG2

7.11e-1212942423530804502
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

BRPF3 ATXN7L2 PSD PPP1R12A SMARCAD1 ZNF318 SAP30 LUZP1 RBM25 SCN5A TAF1 ZNF579 DDX41 TADA3 ITCH ATN1 TCOF1 ADAMTS1 WEE1 NSD2 KAT6A PHRF1 ZC3H18 INO80 SIK3 VANGL2 CTCF SMARCA4 IRX2 CEP170B CDH15 PHLDB2

1.40e-1111162423231753913
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

EED KMT2B RRP1B SMARCAD1 TRIP12 NCBP3 BBX BOD1L1 TAF1 DDX41 SIN3B L3MBTL2 ARID4A NSD2 KAT6A ZC3H18 INO80 IWS1 FAM169A SMARCA4 SENP6 SNAPC4 STAG2

6.31e-116082422336089195
Pubmed

Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.

KIR2DS2 KIR2DL5B KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

1.76e-1013242619120281
Pubmed

Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.

GAK ERCC5 MAP1B RRP1B PPP1R12A CDK11A RB1CC1 LYST MAP3K12 LUZP1 MET PPP1R2B NEK1 FGFR1 DDX41 MAP4K4 CFAP410 WEE1 SIK3 MAP3K6 SPECC1 SDAD1 PPP1R2 PDE4DIP EIF3B MAP3K13 ARHGEF2

2.96e-109102422736736316
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

GAK KMT2B MAP1B ERCC6L RBM10 PPP1R12A ZNF318 LUZP1 KMT2C NEK1 RBM25 BOD1L1 TAF1 MAP4K4 SIN3B IRS4 TCOF1 USP24 SEC23IP SMARCA4 ACIN1

3.64e-105492422138280479
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].

KIR2DS2 KIR2DL5B KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

8.06e-1016242616403292
Pubmed

Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.

KIR2DS2 KIR2DL5B KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

1.24e-0917242620878400
Pubmed

Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.

KIR2DS2 KIR2DL5B KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

1.24e-0917242619450876
Pubmed

Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.

KIR2DS2 KIR2DL5B KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

1.24e-0917242619761533
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.

KIR2DS2 KIR2DL5B KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

1.24e-0917242620650299
Pubmed

[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].

KIR2DS2 KIR2DL5B KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

1.24e-0917242619218127
Pubmed

Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.

KIR2DS2 KIR2DL5B KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

1.85e-0918242620200544
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

MAP1B RRP1B LEMD3 RBM10 CDK11A ZNF318 TRIP12 LUZP1 NCBP3 RBM25 BBX BOD1L1 TAF1 DDX41 TADA3 HSP90AA1 IRS4 ARID4A NSD2 ZC3H18 SLF2 CTCF SMARCA4 SENP6 ACIN1 STAG2

3.78e-099542422636373674
Pubmed

HLA and KIR frequencies in Sicilian Centenarians.

KIR2DS2 KIR2DL5B KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

3.81e-0920242620426625
Pubmed

Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.

KIR2DS2 KIR2DL5B KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

3.81e-0920242620193031
Pubmed

Role of human leukocyte antigen, killer-cell immunoglobulin-like receptors, and cytokine gene polymorphisms in leptospirosis.

KIR2DS2 KIR2DL5B KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A IL4R

4.12e-0935242719683555
Pubmed

Human transcription factor protein interaction networks.

ATXN7L2 KMT2B RRP1B RBM10 CDK11A ZNF318 WASHC2A CXXC1 KMT2C RBM25 BBX NOC4L TAF1 HERC1 TADA3 SIN3B TCF7 IRS4 ATN1 L3MBTL2 ARID4A ZC3H18 INO80 SDAD1 ZBTB14 PDIA4 NOL4L CTCF SMARCA4 SIX5 EIF3B PAX7

6.36e-0914292423235140242
Pubmed

[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

6.99e-0911242519664392
Pubmed

Distribution of KIR genes in the population of unrelated individuals homozygous for ancestral haplotype AH8.1 (HLA-A1B8DR3).

KIR2DS2 KIR2DL5B KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

7.25e-0922242620492596
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

NES MAP1B RRP1B ZNF318 TRIP12 RBM25 SBF1 NOC4L HECTD1 IRS4 COPG1 TCOF1 NSD2 PHRF1 USP24 ZC3H18 PDIA4 CTCF SMARCA4 ACIN1 STAG2

7.81e-096532422122586326
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

LEMD3 MET SBF1 PARD6A ARL13B MAP4K4 GOLGA3 IRS4 ITCH SPECC1 AKAP12 VANGL2 CELSR2 ARHGEF10 SEC23IP EPB41L1 PHLDB2

8.25e-094212421736976175
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

MAP1B TCEAL5 WASHC2A RTN1 NACAD MET PPP1R2B KCNQ2 PPP1R2P1 DLG2 MAP4K4 WNK2 HSP90AA1 ANK2 RETREG2 COPG1 CAMSAP3 USP24 PPP1R2 VANGL2 C1orf198 CELSR2 PDE4DIP FAM169A ASTN1 EIF3B CEP170B EPB41L1

8.58e-0911392422836417873
Pubmed

Systematic analysis of human protein complexes identifies chromosome segregation proteins.

PAGE1 ERCC6L LEMD3 KIZ PPP1R12A CLASP2 WASHC2A PARD6A DDX41 HSP90AA1 RETREG2 L3MBTL2 COPG1 WEE1 GPS1 DYNC2I1 SPECC1 AKAP12 STRIP1 PPP1R2 PDIA4 ZNF106 CTCF SMARCA4 EIF3B STAG2 CEP170B PPP1R12C

1.16e-0811552422820360068
Pubmed

An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.

NES GAK ERCC6L LEMD3 CLASP2 WASHC2A RTN1 BOD1L1 HECTD1 MAP4K4 L3MBTL2 DYNC2I1 STRIP1 PPP1R2 PDIA4 ZNF106 ARHGEF10 TRAPPC12 CLMN SEC23IP SMARCA4 ARHGEF2

1.17e-087332422234672954
Pubmed

Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

1.19e-0812242519936734
Pubmed

[Relationship between CMV reactivation and KIR haplotype/HLA-Cw genotype in patients after unrelated-donor hematopoietic stem cell transplantation.].

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

1.19e-0812242520137308
Pubmed

Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

1.19e-0812242520371502
Pubmed

The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.

MYO9B RILP SBF1 AP5Z1 DNAH5 GOLGA3 HSP90AA1 L3MBTL2 NSD2 DUSP6 KAT6A ARHGEF10 SMARCA4 EIF3B ARHGEF2

1.45e-083322421537433992
Pubmed

Impact of WIN site inhibitor on the WDR5 interactome.

KMT2B CXXC1 KMT2C SBF1 TAF1 SPECC1 ARHGEF2

1.88e-0843242733472061
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

KMT2B RRP1B LEMD3 PPP1R12A PIEZO1 CDK11A CLASP2 ZNF318 LUZP1 KMT2C BBX SBF1 NOC4L ZNF579 DNMBP TADA3 SIN3B NSD2 PHRF1 CAMSAP3 INO80 SPECC1 SDAD1 STRIP1 IWS1 CTCF EIF3B ARHGEF2 STAG2 CEP170B EPB41L1 PPP1R12C

1.89e-0814972423231527615
Pubmed

[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

1.92e-0813242518687225
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

SMARCAD1 ARMCX4 CMYA5 TRIP12 ARL13B KCNQ2 DLG2 TAF1 WDR17 HECTD1 MAP4K4 GOLGA3 PICK1 HSP90AA1 SETMAR ITCH ANK2 TCOF1 ADAMTS1 DYNC2I1 SPECC1 ARHGEF10 SLF2 PDE4DIP SEC23IP SMARCA4 SENP6 ASTN1 ST18

2.95e-0812852422935914814
Pubmed

Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

2.98e-0814242519875891
Pubmed

Multiple sclerosis associates with LILRA3 deletion in Spanish patients.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

2.98e-0814242519421224
Pubmed

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

2.98e-0814242518945962
Pubmed

[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

2.98e-0814242519489269
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

2.98e-0814242515896204
Pubmed

Killer cell immunoglobulin-like receptor gene polymorphism in lymphoproliferative diseases of granular lymphocytes in a Japanese population.

KIR2DS2 KIR2DS1 KIR3DL1 KIR2DL5A

3.39e-086242420528243
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

BRPF3 RRP1B PIEZO1 NACAD KMT2C SBF1 AP5Z1 CACNA1G DNMBP MAP4K4 WNK2 NSD2 PHRF1 INO80 SIK3 ARHGEF10L VANGL2 SENP6

4.10e-085292421814621295
Pubmed

KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

4.44e-0815242517498266
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

4.44e-0815242520082646
Pubmed

Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

4.44e-0815242519850842
Pubmed

[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

4.44e-0815242520356536
Pubmed

Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

4.44e-0815242519926642
Pubmed

Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

4.44e-0815242520207982
Pubmed

Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

4.44e-0815242519493232
Pubmed

Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

4.44e-0815242520643584
Pubmed

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

4.44e-0815242519326408
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

GAK MAP1B ERCC6L RBM10 PPP1R12A ZNF318 RTN1 PPP1R2B NEK1 BOD1L1 HSP90AA1 SIN3B IRS4 ANK2 L3MBTL2 TCOF1 AKAP12 CTCF CLMN SEC23IP FAM169A SMARCA4 SENP6 ACIN1

4.71e-089342422433916271
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

NES MAP1B RRP1B RBM10 TRIP12 CXXC1 RBM25 BBX SBF1 NOC4L DDX41 MAP4K4 HSP90AA1 TCOF1 NSD2 POLR2D ZC3H18 INO80 SIK3 SDAD1 IWS1 VANGL2 SMARCA4 ACIN1 EIF3B ARHGEF2

4.76e-0810822422638697112
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

MAP1B CACNA2D2 KIZ PPP1R12A OBSCN CLASP2 MEIS3 ARHGEF16 MAP3K12 KMT2C TSC22D1 BOD1L1 ANKRD12 HECTD1 MLPH WNK2 PRUNE2 ITCH RASA2 NSD2 PCDH11Y KAT6A CAMSAP3 DYNC2I1 CPT1A CLMN RASEF STAG2 CEP170B EPB41L1 CDH15

5.83e-0814892423128611215
Pubmed

Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

6.42e-0816242519897003
Pubmed

Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

6.42e-0816242519309280
Pubmed

Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

6.42e-0816242520652381
Pubmed

No association of KIR genes with Behcet's disease.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

6.42e-0816242517868255
Pubmed

Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

6.42e-0816242520331834
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

6.42e-0816242519000141
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

6.42e-0816242520670355
Pubmed

Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

6.42e-0816242518668235
Pubmed

Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

6.42e-0816242519527230
Pubmed

Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

6.42e-0816242519279038
Pubmed

A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

6.42e-0816242518643961
Pubmed

HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

6.42e-0816242520210919
Pubmed

[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

9.05e-0817242519968064
Pubmed

Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

9.05e-0817242520483367
Pubmed

The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

9.05e-0817242520173792
Pubmed

KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

9.05e-0817242519169284
Pubmed

Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.

MAP1B ERCC6L LEMD3 RNF19B ZNF318 CXXC1 KMT2C NEK1 SBF1 FGD5 ZNF579 GPS1 KAT6A LEMD2 SIK3 AKAP12 TRAPPC12 CLMN PDE4DIP SSH2

9.54e-086892422036543142
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

ERCC5 MAP1B NHSL2 PPP1R12A ZNF318 TRIP12 LYST CXXC1 LUZP1 BBX DLG2 BOD1L1 FGFR1 MLPH CAVIN2 PICK1 HSP90AA1 IRS4 ANK2 NSD2 GPS1 CAMSAP3 CAPN11 PDIA4 SEC23IP FAM169A ACIN1 ARHGEF2 STAG2 UTP14C

9.89e-0814422423035575683
Pubmed

Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

1.25e-0718242520580654
Pubmed

Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

1.25e-0718242520519398
Pubmed

Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

1.25e-0718242519846535
Pubmed

Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

1.25e-0718242519630074
Pubmed

Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

1.25e-0718242519046302
Pubmed

KIR haplotype content at the allele level in 77 Northern Irish families.

KIR2DS2 KIR2DS4 KIR3DL1 KIR2DL5A

1.57e-078242417200871
Pubmed

Primary cilia are WNT-transducing organelles whose biogenesis is controlled by a WNT-PP1 axis.

PPP1R2B ARL13B PPP1R2P1 PPP1R2

1.57e-078242436693320
Pubmed

Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

1.68e-0719242520600442
Pubmed

KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

1.68e-0719242518571006
Pubmed

Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

1.68e-0719242518778326
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

1.68e-0719242518848853
Pubmed

Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.

WASHC2A DNMBP MAP4K4 L3MBTL2 CAMSAP3 SPECC1 RABL6 C1orf198 EIF3B ARHGEF2 CEP170B PHLDB2

2.27e-072512421229778605
Pubmed

Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1

2.80e-079242418340360
Pubmed

Activating killer cell immunoglobulin-like receptors 3DS1 and 2DS1 protect against developing the severe form of recurrent respiratory papillomatosis.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

2.91e-0721242519861144
Pubmed

Promoter variants of KIR2DL5 add to diversity and may impact gene expression.

KIR2DL5B KIR2DS1 KIR2DL5A

3.33e-073242318461314
Pubmed

Structural basis for regulation of protein phosphatase 1 by inhibitor-2.

PPP1R2B PPP1R2P1 PPP1R2

3.33e-073242317636256
Pubmed

Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus.

KIR2DL5B KIR2DS1 KIR2DS4 KIR3DL1

4.65e-0710242421206914
Pubmed

Mouse screen reveals multiple new genes underlying mouse and human hearing loss.

BRPF3 TCEAL5 WASHC2A NACAD USP20 GSDME BBX DLG2 HERC1 HSP90AA1 AMFR SETMAR L3MBTL2 COPG1 ARID4A CAMSAP3 USP24 OAS1 SIK3 CAPN11 PDIA4 ZNF106 CTCF CEP41 SNAPC4 ST18

6.71e-0712422422630973865
Pubmed

Natural killer cells and immune surveillance.

KIR2DS2 KIR2DS4 KIR3DL1 KIR2DL5A

7.26e-0711242418830515
Pubmed

Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.

RBM10 NACAD KMT2C BBX NYNRIN WNK2 PCDH11Y PRDM7 AKAP12 PDE4DIP SIX5

8.24e-072332421137704626
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

NES MAP1B RRP1B MYO9B RBM10 ZNF318 RB1CC1 TRIP12 NCBP3 RBM25 NOC4L DDX41 MAP4K4 IRS4 TCOF1 SPECC1 PDIA4 SMARCA4 ACIN1 EIF3B ARHGEF2 STAG2 PHLDB2

9.45e-0710242422324711643
Pubmed

A comprehensive resource of interacting protein regions for refining human transcription factor networks.

MAP1B PPP1R12A TCEAL5 HSP90AA1 ANK2 USP24 AKAP12 SLF2 SENP6 ACIN1

1.03e-061912421020195357
Pubmed

Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1

1.08e-0612242419181658
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia].

KIR2DS2 KIR2DS4 KIR3DL1 KIR2DL5A

1.08e-0612242417490516
Pubmed

Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.

MAP1B RTN1 KCNQ2 DLG2 AMFR ANK2 CAMSAP3 SPECC1 STRIP1 C1orf198 ARHGEF2 CEP170B EPB41L1

1.13e-063472421317114649
InteractionSFN interactions

MAP1B ERCC6L PPP1R12A CLASP2 ARHGEF16 TRIP12 LYST LUZP1 MET RBM25 DNMBP HECTD1 MAP4K4 IRS4 ITCH WEE1 CAMSAP3 ZC3H18 SIK3 MAP3K6 SPECC1 RGS12 PPP1R2 ARHGEF10 CLMN SSH2 ARHGEF2 CEP170B PHLDB2 PPP1R12C GPRIN2

1.39e-1069223531int:SFN
InteractionCSNK2A1 interactions

ERCC5 KMT2B RRP1B RBM10 HLX CDK11A CLASP2 SMARCAD1 LYST SAP30 PPP1R1B TAF1 DDX41 HSP90AA1 TAF1D IRS4 ITCH ATN1 TCOF1 WEE1 KAT6A PHRF1 USP24 ZC3H18 NMD3 IWS1 PPP1R2 LPIN3 CTDP1 SNAI2 SMARCA4 ACIN1 EIF3B MAP3K13 PAX7 SNAPC4

4.87e-1095623536int:CSNK2A1
InteractionYWHAH interactions

NES ERCC6L NHSL2 PPP1R12A CLASP2 RB1CC1 ARHGEF16 TRIP12 LYST LUZP1 NEK1 SBF1 PARD6A BOD1L1 HERC1 DNMBP HECTD1 MAP4K4 CFAP410 WNK2 HSP90AA1 IRS4 WEE1 CAMSAP3 SIK3 MAP3K6 SPECC1 RGS12 PDIA4 LPIN3 ZNF106 SLF2 CLMN SSH2 ARHGEF2 CEP170B EPB41L1 PHLDB2 PPP1R12C

5.02e-10110223539int:YWHAH
InteractionNUP43 interactions

ERCC5 KMT2B RRP1B PPP1R12A SMARCAD1 ZNF318 TRIP12 NCBP3 BBX TONSL BOD1L1 TADA3 ATN1 L3MBTL2 ARID4A NSD2 PHRF1 ZC3H18 INO80 SDAD1 IWS1 SLF2 CTCF TRAPPC12 FAM169A SMARCA4 SENP6 ACIN1

1.17e-0962523528int:NUP43
InteractionCSNK2A2 interactions

BRPF3 ERCC5 RRP1B RBM10 HLX CDK11A LYST SAP30 SBF1 PPP1R1B DDX41 PICK1 HSP90AA1 TAF1D IRS4 TCOF1 WEE1 KAT6A EIF1AD PHRF1 ZC3H18 SDAD1 STRIP1 PPP1R2 LPIN3 ZNF106 CTDP1 SMARCA4 EIF3B SNAPC4

1.47e-0971823530int:CSNK2A2
InteractionYWHAG interactions

EED ERCC6L NHSL2 PPP1R12A CLASP2 RB1CC1 ARHGEF16 TRIP12 LYST LUZP1 NEK1 SBF1 BOD1L1 DNMBP DDX41 HECTD1 MAP4K4 CFAP410 HSP90AA1 IRS4 ITCH WEE1 CAMSAP3 USP24 SIK3 MAP3K6 SPECC1 RGS12 PDIA4 LPIN3 ZNF106 CLMN ACIN1 SSH2 ARHGEF2 CEP170B EPB41L1 PHLDB2 PPP1R12C

1.62e-08124823539int:YWHAG
InteractionPOLR1G interactions

KMT2B RRP1B CDK11A SMARCAD1 TRIP12 NCBP3 BBX TAF1 HECTD1 TADA3 TCOF1 NSD2 POLR2D KAT6A EIF1AD ZC3H18 SDAD1 IWS1 ZNF106 CTCF SMARCA4 STAG2

7.29e-0848923522int:POLR1G
InteractionYWHAE interactions

MAP1B RBM10 PPP1R12A CDK11A CLASP2 RB1CC1 ARHGEF16 TRIP12 LYST LUZP1 NEK1 SBF1 FGD5 DNMBP HECTD1 GOLGA3 CFAP410 WNK2 HSP90AA1 IRS4 POLR2D CAMSAP3 ZC3H18 SIK3 SPECC1 RGS12 PPP1R2 PDIA4 LPIN3 ZNF106 SEC23IP SSH2 ARHGEF2 CEP170B EPB41L1 PHLDB2 GPRIN2

1.77e-07125623537int:YWHAE
InteractionZNF330 interactions

KMT2B RRP1B LEMD3 CDK11A SMARCAD1 TRIP12 NCBP3 BBX TAF1 DDX41 PICK1 NSD2 ZC3H18 SDAD1 IWS1 ZNF106 FAM169A SMARCA4 SENP6 STAG2

3.10e-0744623520int:ZNF330
InteractionSENP3 interactions

EED RRP1B MYO9B CDK11A TRIP12 NCBP3 BBX TONSL TAF1 HERC1 HECTD1 HSP90AA1 COPG1 KAT6A ZC3H18 ACIN1

5.36e-0730123516int:SENP3
InteractionSIN3A interactions

BRPF3 EED MAP1B SMARCAD1 SAP30 BOD1L1 TAF1 DDX41 HECTD1 HSP90AA1 SIN3B L3MBTL2 ARID4A NSD2 CTCF CTDP1 SNAI2 SMARCA4

5.61e-0738023518int:SIN3A
InteractionCHD4 interactions

EED RRP1B RBM10 PPP1R12A CDK11A SMARCAD1 TRIP12 CXXC1 SAP30 NCBP3 RBM25 NOC4L DDX41 HECTD1 GOLGA3 L3MBTL2 TCOF1 NSD2 KAT6A ZC3H18 SIK3 SDAD1 IWS1 RABL6 NOL4L SNAI2 SMARCA4 ACIN1 EIF3B

1.70e-0693823529int:CHD4
InteractionYWHAB interactions

EED PPP1R12A CLASP2 RB1CC1 ARHGEF16 TRIP12 LYST LUZP1 NEK1 FGFR1 DNMBP HECTD1 CFAP410 HSP90AA1 IRS4 WEE1 KAT6A CAMSAP3 SIK3 SPECC1 RGS12 PDIA4 LPIN3 ZNF106 SSH2 ARHGEF2 CEP170B EPB41L1 PHLDB2 PPP1R12C

2.71e-06101423530int:YWHAB
InteractionTAF10 interactions

ERCC5 TRIP12 TAF1 TADA3 GOLGA3 KAT6A SMARCA4 ARHGEF2 SNAPC4

4.55e-061072359int:TAF10
InteractionH3C3 interactions

EED KMT2B RRP1B SMARCAD1 TRIP12 NCBP3 BBX TONSL BOD1L1 TAF1 SIN3B L3MBTL2 ARID4A NSD2 ZC3H18 IWS1 FAM169A SMARCA4 STAG2

6.04e-0649523519int:H3C3
InteractionTOP3B interactions

KMT2B MYO9B PIEZO1 OBSCN CLASP2 WASHC2A LYST SAP30 KMT2C SBF1 SCN5A KCNQ2 FGFR1 ZNF579 HERC1 DNMBP HECTD1 WNK2 PICK1 B4GALNT4 NSD2 KAT6A VEPH1 INO80 ARHGEF10L RABL6 LPIN3 CELSR2 ADAMTS7 TRAPPC12 FURIN CTDP1 ACIN1 ARHGEF2 SNAPC4 IL4R CEP170B

7.39e-06147023537int:TOP3B
InteractionKCNA3 interactions

MAP1B ERCC6L LUZP1 KMT2C RBM25 BOD1L1 DNAH5 MAP4K4 HSP90AA1 DNHD1 IRS4 ANK2 TCOF1 USP24 ZC3H18 SPECC1 SDAD1 AKAP12 VANGL2 PDIA4 RABL6 C1orf198 SEC23IP SMARCA4 SENP6 EPB41L1

1.13e-0587123526int:KCNA3
InteractionH2BC8 interactions

EED ERCC5 KMT2B LEMD3 SMARCAD1 TRIP12 CXXC1 NCBP3 BBX NOC4L TADA3 ARID4A NSD2 IWS1 PPP1R2 CTCF FAM169A SMARCA4 SENP6 STAG2

1.49e-0557623520int:H2BC8
InteractionSMC5 interactions

EED MAP1B RRP1B LEMD3 RBM10 CDK11A ZNF318 TRIP12 LUZP1 NCBP3 RBM25 BBX BOD1L1 TAF1 DDX41 HECTD1 TADA3 HSP90AA1 IRS4 ARID4A NSD2 ZC3H18 SLF2 CTCF SMARCA4 SENP6 ACIN1 STAG2

1.65e-05100023528int:SMC5
InteractionMAPRE3 interactions

MYO9B CLASP2 LUZP1 NEK1 DNMBP MAP4K4 PICK1 CAMSAP3 SPECC1 PDE4DIP ARHGEF2 CEP170B

1.74e-0523023512int:MAPRE3
InteractionSNRNP40 interactions

KMT2B RRP1B RBM10 SMARCAD1 ZNF318 RBM25 TONSL DDX41 HECTD1 TADA3 ATN1 TCOF1 NSD2 GPS1 KAT6A PHRF1 ZC3H18 CTCF SMARCA4 SENP6 ACIN1

1.97e-0563723521int:SNRNP40
InteractionMYH10 interactions

EED PPP1R12A USP20 RBM25 FGD5 HECTD1 GOLGA3 AMFR TCOF1 ZC3H18 SPECC1 PDIA4 RABL6 CTCF EIF3B

2.23e-0535923515int:MYH10
InteractionH3-3A interactions

EED KMT2B RRP1B SMARCAD1 TRIP12 NCBP3 KMT2C BBX BOD1L1 FGFR1 TAF1 DDX41 L3MBTL2 NSD2 GPS1 KAT6A DYNC2I1 INO80 IWS1 SMARCA4 SENP6 SNAPC4 STAG2

2.41e-0574923523int:H3-3A
InteractionEEF1AKMT3 interactions

GAK ERCC6L CDK11A SMARCAD1 TRIP12 SBF1 TONSL HERC1 DNMBP WNK2 HSP90AA1 MAP3K6 ARHGEF10 CTDP1 ARHGEF2

2.62e-0536423515int:EEF1AKMT3
InteractionSMARCA5 interactions

EED PPP1R12A SMARCAD1 RTN1 SAP30 HECTD1 MAP4K4 GOLGA3 L3MBTL2 NSD2 GPS1 ZC3H18 INO80 RABL6 SMARCA4 STAG2

3.16e-0541523516int:SMARCA5
InteractionPHF20 interactions

KMT2B CXXC1 KMT2C TAF1 TADA3 ATN1

3.42e-05532356int:PHF20
InteractionEPHA2 interactions

LEMD3 SMARCAD1 ARHGEF16 MET SBF1 PARD6A ARL13B FGFR1 MAP4K4 GOLGA3 HSP90AA1 IRS4 ITCH SPECC1 ZBTB14 AKAP12 VANGL2 CELSR2 ARHGEF10 SEC23IP EPB41L1 PHLDB2

3.84e-0571923522int:EPHA2
InteractionYWHAQ interactions

PPP1R12A CLASP2 ARHGEF16 TRIP12 LYST MAP3K12 LUZP1 NEK1 SBF1 FGD5 DNMBP HECTD1 CFAP410 HSP90AA1 IRS4 ITCH WEE1 CAMSAP3 SIK3 SPECC1 RGS12 LPIN3 ZNF106 SSH2 ARHGEF2 CEP170B EPB41L1 PHLDB2 PPP1R12C

4.68e-05111823529int:YWHAQ
InteractionMEX3A interactions

MYO9B RILP SBF1 AP5Z1 DNAH5 GOLGA3 HSP90AA1 L3MBTL2 NSD2 DUSP6 KAT6A ARHGEF10 SMARCA4 EIF3B ARHGEF2

4.83e-0538423515int:MEX3A
InteractionYWHAZ interactions

EED PPP1R12A CLASP2 RB1CC1 ARHGEF16 TRIP12 LYST LUZP1 NEK1 SBF1 PARD6A DNMBP HECTD1 GOLGA3 CFAP410 WNK2 HSP90AA1 IRS4 WEE1 KAT6A CAMSAP3 ZC3H18 SIK3 SPECC1 RGS12 LPIN3 SSH2 ARHGEF2 CEP170B EPB41L1 PHLDB2 PPP1R12C

6.66e-05131923532int:YWHAZ
InteractionATN1 interactions

KMT2B RBM10 LYST CXXC1 KMT2C TAF1 TADA3 ITCH ATN1 KAT6A

7.16e-0518723510int:ATN1
InteractionRCOR1 interactions

KMT2B PPP1R12A ZNF318 RB1CC1 LUZP1 NEK1 TAF1 GOLGA3 SIN3B IRS4 L3MBTL2 ARID4A CAMSAP3 USP24 FAM169A SMARCA4 PAX7

7.38e-0549423517int:RCOR1
InteractionATRX interactions

LUZP1 NEK1 TONSL ATN1 ANK2 WEE1 NSD2 KAT6A SLF2 CTCF SENP6 EIF3B

7.46e-0526723512int:ATRX
InteractionGSK3B interactions

EED MAP1B RRP1B CLASP2 WASHC2A TRIP12 RTN1 LUZP1 MET PPP1R2B NEK1 TONSL HECTD1 GOLGA3 PICK1 HSP90AA1 COPG1 GPS1 CAMSAP3 PPP1R2 PDIA4 SNAI2 EIF3B CEP170B

8.37e-0586823524int:GSK3B
InteractionPRNP interactions

MAP1B ERCC6L LEMD3 RNF19B ZNF318 CXXC1 RTN1 KMT2C PPP1R2B NEK1 SBF1 DLG2 FGD5 ZNF579 HSP90AA1 AMFR ANK2 GPS1 KAT6A LEMD2 IRGQ SIK3 AKAP12 RABL6 TRAPPC12 CLMN PDE4DIP SSH2 EPB41L1

8.71e-05115823529int:PRNP
InteractionHERC2 interactions

GAK EED MYO9B RB1CC1 USP20 RBM25 TAF1 HERC1 DDX41 HECTD1 ANK2 COPG1 FHOD3 CPT1A RGS12 SEC23IP EIF3B

9.19e-0550323517int:HERC2
InteractionCAVIN2 interactions

MAP1B RB1CC1 CAVIN2 TCOF1 CTCF ACIN1

9.20e-05632356int:CAVIN2
InteractionHDAC1 interactions

EED KMT2B SMARCAD1 ZNF318 RB1CC1 SAP30 LUZP1 NEK1 RBM25 BBX TAF1 HECTD1 GOLGA3 PGBD3 HSP90AA1 SIN3B IRS4 L3MBTL2 ARID4A NSD2 GPS1 CAMSAP3 USP24 CTCF SEC23IP SNAI2 SMARCA4 STAG2

9.98e-05110823528int:HDAC1
InteractionRERE interactions

KMT2B CXXC1 TAF1 TADA3 ATN1 L3MBTL2 KAT6A

1.08e-04932357int:RERE
InteractionSMARCA4 interactions

EED PPP1R12A SMARCAD1 SAP30 RBM25 PARD6A HECTD1 SIN3B L3MBTL2 NSD2 KAT6A USP24 SIK3 RABL6 CTCF SMARCA4

1.12e-0446223516int:SMARCA4
InteractionARID4B interactions

BRPF3 EED NHSL2 SAP30 DDX41 HECTD1 SIN3B ARID4A SMARCA4 PAX7

1.20e-0419923510int:ARID4B
InteractionSMC1A interactions

EED RBM10 SMARCAD1 RB1CC1 SAP30 MET HECTD1 WNK2 L3MBTL2 COPG1 ZC3H18 ARHGEF10L CTCF ACIN1 STAG2

1.24e-0441823515int:SMC1A
InteractionKANSL1 interactions

KMT2B CXXC1 TADA3 ATN1 L3MBTL2 KAT6A CTCF

1.32e-04962357int:KANSL1
InteractionWWTR1 interactions

GAK MAP1B ERCC6L RBM10 PPP1R12A ZNF318 LUZP1 NEK1 RBM25 MAP4K4 SIN3B IRS4 USP24 SEC23IP SMARCA4

1.38e-0442223515int:WWTR1
InteractionCENPA interactions

ERCC5 KMT2B RRP1B LEMD3 TRIP12 NCBP3 BBX TAF1 NSD2 KAT6A SDAD1 SLF2 SENP6 STAG2

1.47e-0437723514int:CENPA
InteractionBRPF3 interactions

BRPF3 ZNF318 SAP30 TAF1 WEE1 KAT6A CEP170B CDH15 PHLDB2

1.48e-041662359int:BRPF3
InteractionRPL31 interactions

EED ERCC5 RRP1B CDK11A NCBP3 BBX NOC4L TAF1 DDX41 HECTD1 TCOF1 NSD2 KAT6A ZC3H18 SDAD1 IWS1 ZNF106 CTCF ACIN1 EIF3B

1.48e-0468023520int:RPL31
InteractionSAP30 interactions

BRPF3 EED LYST SAP30 HSP90AA1 SIN3B ARID4A GPS1 SMARCA4

1.55e-041672359int:SAP30
InteractionCXXC1 interactions

KMT2B CXXC1 KMT2C BOD1L1 TADA3 HSP90AA1 ATN1 EPB41L1

1.62e-041322358int:CXXC1
InteractionBRD2 interactions

ERCC6L TONSL TAF1 DDX41 TADA3 ADAMTS1 NSD2 USP24 INO80 VANGL2 CTCF SMARCA4 ACIN1 IRX2 EPB41L1

1.65e-0442923515int:BRD2
InteractionFBXO10 interactions

NECTIN4 HECTD1 HSP90AA1 GPS1 CELSR2

1.73e-04452355int:FBXO10
InteractionDHX40 interactions

ERCC5 RRP1B CDK11A ZNF318 NCBP3 TAF1 HERC1 DDX41 ZC3H18 SDAD1 ZNF106

1.73e-0424923511int:DHX40
InteractionSIRT7 interactions

NES MAP1B RRP1B ZNF318 TRIP12 RBM25 SBF1 NOC4L HECTD1 IRS4 COPG1 TCOF1 NSD2 PHRF1 USP24 ZC3H18 PDIA4 CTCF SMARCA4 ACIN1 STAG2

1.78e-0474423521int:SIRT7
InteractionKMT2C interactions

KMT2B CXXC1 KMT2C TSC22D1 BOD1L1 ATN1 TCOF1 PAX7

1.79e-041342358int:KMT2C
InteractionHMGB1 interactions

MAP1B ZNF318 TAF1 HSP90AA1 NSD2 DYNC2I1 ZC3H18 IWS1 CTCF SEC23IP CTDP1 SMARCA4 ACIN1 SIX5 EIF3B UTP14C

1.99e-0448623516int:HMGB1
InteractionNAA40 interactions

GAK EED MAP1B ERCC6L RBM10 PPP1R12A ZNF318 RTN1 PPP1R2B NEK1 BOD1L1 HSP90AA1 SIN3B IRS4 ANK2 L3MBTL2 TCOF1 AKAP12 CTCF CLMN SEC23IP FAM169A SMARCA4 SENP6 ACIN1

2.02e-0497823525int:NAA40
InteractionCBX3 interactions

BRPF3 EED ATXN7L2 KMT2B LEMD3 PPP1R12A CDK11A SMARCAD1 TRIP12 BBX FGD5 MAP4K4 TADA3 L3MBTL2 TCOF1 NSD2 SMARCA4 SENP6 STAG2

2.18e-0464623519int:CBX3
InteractionCHD3 interactions

EED RRP1B RBM10 SAP30 NCBP3 TSC22D1 RBM25 NOC4L TAF1 DDX41 HECTD1 HSP90AA1 SIN3B RETREG2 KAT6A ZC3H18 SDAD1 SMARCA4 ACIN1 EIF3B STAG2

2.25e-0475723521int:CHD3
InteractionEIF3I interactions

NES EED MAP1B CDK11A WASHC2A TRIP12 HECTD1 ZC3H18 CTCF EIF3B EPB41L1

2.35e-0425823511int:EIF3I
InteractionSETD1B interactions

KMT2B CXXC1 SAP30 KMT2C BOD1L1 ATN1

2.43e-04752356int:SETD1B
InteractionMYO1C interactions

GAK EED RBM10 PPP1R12A USP20 NCBP3 ARL13B FGD5 TADA3 ZC3H18 SPECC1 FURIN EIF3B PHLDB2

2.50e-0439723514int:MYO1C
InteractionPOLR1E interactions

RRP1B CDK11A SMARCAD1 BBX TAF1 HECTD1 TAF1D TCOF1 POLR2D EIF1AD SDAD1 ZNF106 CTCF

2.52e-0435023513int:POLR1E
InteractionSAP18 interactions

SAP30 RBM25 TAF1 TADA3 PHRF1 ZC3H18 VANGL2 CELSR2 CTCF SMARCA4 ACIN1 EPB41L1

2.58e-0430523512int:SAP18
InteractionH3-4 interactions

BRPF3 EED SAP30 KMT2C TONSL TAF1 DNAH5 TADA3 HSP90AA1 ANO4 SIN3B L3MBTL2 NSD2 KAT6A PHRF1

2.63e-0444823515int:H3-4
InteractionDYNLL2 interactions

EED KMT2C NEK1 DLG2 IFFO1 DYNC2I1 ZC3H18 STRIP1 PDE4DIP CEP170B GPRIN2

2.77e-0426323511int:DYNLL2
InteractionMYCBP2 interactions

NES EED PPP1R12A CLASP2 DLG2 HECTD1 MAP4K4 ANK2 NSD2 RGS12 AKAP12 SSH2 ARHGEF2

2.89e-0435523513int:MYCBP2
InteractionTRIM36 interactions

CLASP2 LUZP1 NEK1 HSP90AA1 CAMSAP3 SPECC1 ARHGEF2 CEP170B

2.93e-041442358int:TRIM36
InteractionC11orf52 interactions

MET SBF1 ARL13B MAP4K4 IRS4 ITCH SPECC1 AKAP12 VANGL2 C1orf198 EPB41L1 PHLDB2

3.08e-0431123512int:C11orf52
InteractionAP1M1 interactions

GAK EED RNF19B C7orf57 FGFR1 PICK1 FAM219B ZBTB14 VANGL2 FURIN

3.35e-0422623510int:AP1M1
InteractionEPB41L3 interactions

ARHGEF16 CXXC1 NACAD ARL13B BOD1L1 HECTD1 TAF1D ZC3H18 VANGL2 ACIN1 EPB41L1

3.68e-0427223511int:EPB41L3
InteractionCCDC144CP interactions

CCDC144CP HSP90AA1

4.03e-0432352int:CCDC144CP
InteractionKIAA1210 interactions

KIAA1210 ITCH

4.03e-0432352int:KIAA1210
InteractionCSNK2B interactions

KMT2B RRP1B CDK11A LYST MAP4K4 PGBD3 HSP90AA1 TAF1D TCOF1 WEE1 KAT6A LEMD2 PHRF1 ZC3H18 ZNF106 CTCF CTDP1 SNAPC4

4.10e-0462523518int:CSNK2B
InteractionAPEX1 interactions

EED ERCC5 KMT2B RRP1B LRRC37A3 PPP1R12A CDK11A MEIS3 TRIP12 GSDME BBX FGFR1 TCOF1 ARID4A NSD2 KAT6A INO80 SDAD1 ZBTB14 IWS1 PDIA4 C1orf198 MZF1 CTDP1 FAM169A POLI SMARCA4 EIF3B STAG2

4.17e-04127123529int:APEX1
InteractionCHAF1A interactions

PPP1R12A SMARCAD1 TRIP12 RTN1 SAP30 DDX41 GPS1 KAT6A AKAP12 TIGD6 SMARCA4 EIF3B

4.21e-0432223512int:CHAF1A
InteractionRBBP4 interactions

EED CDK11A SAP30 BBX HECTD1 GOLGA3 PGBD3 HSP90AA1 SIN3B L3MBTL2 ARID4A GPS1 ZC3H18 SDAD1 CTCF SMARCA4 STAG2

4.24e-0457323517int:RBBP4
InteractionSIRT6 interactions

RRP1B LEMD3 RBM10 ZNF318 TRIP12 SBF1 PARD6A TONSL HECTD1 IRS4 TCOF1 WEE1 POLR2D DYNC2I1 SDAD1 CELSR2 SMARCA4 ARHGEF2

4.33e-0462823518int:SIRT6
Cytoband19q13.4

KIR2DS2 KIR2DS1 KIR2DS4 KIR3DL1 MZF1

6.40e-0579242519q13.4
GeneFamilyCD molecules|Killer cell immunoglobulin like receptors

KIR2DS2 KIR2DL5B KIR2DS1 KIR2DS4 KIR3DL1 KIR2DL5A

6.63e-09181576620
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

MAP1B RRP1B PPP1R12A RB1CC1 PPP1R1B DLG2 PHRF1 CAMSAP3 PPP1R2 TMEM132D PPP1R12C

5.27e-0718115711694
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

OBSCN ARHGEF16 FGD5 DNMBP ARHGEF10L ARHGEF10 ARHGEF2

1.65e-06661577722
GeneFamilyPHD finger proteins

BRPF3 KMT2B CXXC1 KMT2C NSD2 KAT6A PHRF1

1.33e-0590157788
GeneFamilyTALE class homeoboxes and pseudogenes

MEIS3 IRX3 MEIS3P2 IRX2

7.05e-05261574526
GeneFamilyCavins

CAVIN2 CAVIN3

4.44e-04415721326
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

PSD ARHGEF16 SBF1 FGD5 RASA2 VEPH1 ARHGEF2 PHLDB2

4.45e-042061578682
GeneFamilyMitogen-activated protein kinase kinase kinases|RAF family

MAP3K12 MAP3K6 MAP3K13

1.14e-03241573654
GeneFamilyLEM domain containing

LEMD3 LEMD2

1.53e-03715721087
GeneFamilyClassical BAR domain containing

DNMBP PICK1

2.03e-03815721292
GeneFamilyHistone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex

SAP30 SIN3B

2.59e-03915721306
GeneFamilyZinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family

KMT2B KMT2C NSD2

3.16e-03341573487
GeneFamilyZinc fingers CXXC-type

KMT2B CXXC1

4.67e-03121572136
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HGABA

SYCP2L TMEM169 PSD MAP1B TCEAL5 ZNF318 RB1CC1 LYST RTN1 DLG2 BOD1L1 CACNA1G ANKRD12 HERC1 GOLGA3 B4GALNT4 ANK2 RETREG2 ARID4A FHOD3 IRX3 IRGQ SIK3 STRIP1 NOL4L PDE4DIP FAM169A SSH2 IRX2 EPB41L1 CCDC144A

2.72e-08110623831M39071
CoexpressionGINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN

MYO9B RBM10 AP5Z1 CFAP410 PICK1 ATN1 L3MBTL2 TCOF1 LEMD2 FURIN SMARCA4 ACIN1 EIF3B ARHGEF2 SNAPC4 PPP1R12C

9.38e-0833823816M17094
CoexpressionAIZARANI_LIVER_C20_LSECS_3

MAP1B LUZP1 RBM25 FGFR1 HERC1 DNMBP CAVIN2 ADAMTS1 DUSP6 DYNC2I1 AKAP12 IL4R CCDC144A

3.38e-0629523813M39121
CoexpressionGSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP

KMT2B MYO9B KMT2C HERC1 MAP4K4 NSD2 USP24 IWS1 ZNF106 CELSR2

6.26e-0618023810M8239
CoexpressionGSE3982_MAST_CELL_VS_MAC_UP

CACNA2D2 RBM10 NCBP3 HERC1 DNMBP CAVIN2 TAF1D SLF2 CTCF STAG2

1.51e-0519923810M5429
CoexpressionFOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN

SAP30 NCBP3 MET TONSL KCNQ2 BOD1L1 KIR3DL1 SIN3B KAT6A USP24 OAS1 CAVIN3 INO80 PRDM7 MAP3K6 SPECC1 ARHGEF10L RABL6 ZNF106 PLCE1

1.75e-0574623820M40863
CoexpressionBUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP

KMT2B KIZ RNF19B RB1CC1 LYST TSC22D1 RBM25 AP5Z1 FGFR1 ANKRD12 HSP90AA1 ITCH RETREG2 SIK3 CPT1A SLF2 PDE4DIP FAM169A SENP6 ARHGEF2 STAG2

2.19e-0582223821M6782
CoexpressionAIZARANI_LIVER_C9_LSECS_1

CNTNAP3B MAP1B LUZP1 FGFR1 HERC1 CAVIN2 DUSP6 VASH1 DYNC2I1 MAP3K6 AKAP12 IL4R

2.42e-0530423812M39113
CoexpressionAtlasFacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5

GAK PPP1R12A MAP3K12 SAP30 LUZP1 PPP1R2B NEK1 GSDME BBX BOD1L1 TAF1 ZNF579 HECTD1 ITCH ARID4A WEE1 KAT6A USP24 DYNC2I1 IRX3 IWS1 SLF2 CEP41 FAM169A ASTN1 EPB41L1

6.07e-0962923126Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlasDevelopingKidney_e11.5_metaneph mesench_emap-3843_k-means-cluster#3_top-relative-expression-ranked_1000

RRP1B ERCC6L GSDME TONSL NOC4L MAP4K4 TCOF1 NSD2 EIF1AD SPECC1 SDAD1 VANGL2 CLMN CEP41 ASTN1 ARHGEF2

3.97e-0637623116gudmap_developingKidney_e11.5_metaneph mesench_1000_k3
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500

NES SYCP2L MAP1B RTN1 SAP30 LUZP1 PPP1R2B NEUROG1 HSP90AA1 IRS4 ARID4A CAMSAP3 FHOD3 IRX3 IWS1 CELSR2 FAM169A ST18

9.48e-0649823118Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000

NES SYCP2L MAP1B KIZ RTN1 SAP30 LUZP1 PPP1R2B NEK1 NEUROG1 BOD1L1 ZNF579 HECTD1 WNK2 HSP90AA1 IRS4 TCOF1 ARID4A CAMSAP3 FHOD3 IRX3 IWS1 CELSR2 FAM169A SMARCA4 ASTN1 ST18

1.08e-0598923127Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlasFacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000

SYCP2L BRPF3 PPP1R12A TCEAL5 C8orf34 SAP30 LUZP1 PPP1R2B GSDME BBX TONSL BOD1L1 TAF1 ZNF579 TCOF1 ARID4A KAT6A CAMSAP3 DYNC2I1 IRX3 IWS1 SLF2 FAM169A RASEF ASTN1 ARHGEF2 ST18

1.08e-0598923127Facebase_RNAseq_e10.5_Maxillary Arch_1000
CoexpressionAtlasFacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5

MAP1B SAP30 LUZP1 PPP1R2B FHOD3 IRX3 IWS1 ZNF106 CELSR2 FAM169A UTP14C

1.54e-0520423111Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4

GAK MAP1B PPP1R12A MAP3K12 PPP1R2B NEK1 BOD1L1 TAF1 HECTD1 ITCH ARID4A WEE1 KAT6A USP24 CELSR2 CTCF CEP41 SENP6 STAG2

2.99e-0559523119Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlasFacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000

NES SYCP2L MAP1B RTN1 SAP30 LUZP1 PPP1R2B NOC4L HSP90AA1 TAF1D IRS4 L3MBTL2 TCOF1 EIF1AD CAMSAP3 FHOD3 IRX3 SDAD1 NMD3 IWS1 ZNF106 CELSR2 ADAMTS7 FAM169A PAX7 UTP14C

3.14e-0599123126Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#5

SYCP2L HSP90AA1 IRS4 CAMSAP3 CELSR2 FAM169A

5.23e-05612316Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K5
CoexpressionAtlasDevelopingKidney_e11.5_metaneph mesench_emap-3843_top-relative-expression-ranked_1000

RRP1B ERCC6L GSDME BBX TONSL NOC4L FGD5 FGFR1 DDX41 MAP4K4 ANO4 B4GALNT4 TCOF1 NSD2 EIF1AD SPECC1 SDAD1 PPP1R2 VANGL2 CLMN CEP41 ASTN1 ARHGEF2

5.79e-0585023123gudmap_developingKidney_e11.5_metaneph mesench_1000
CoexpressionAtlasFacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000

SYCP2L LEMD3 TCEAL5 APOBR C8orf34 MET PPP1R2B NEUROG1 NOC4L DLG2 CACNA1G ZNF579 DOC2B ADAMTSL1 IRS4 DUSP6 CAMSAP3 CPT1A CELSR2 FAM169A RASEF ASTN1 PAX7 ST18 CEP170B

6.30e-0597323125Facebase_RNAseq_e9.5_Olfactory Placode_1000
CoexpressionAtlasFacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2

LEMD3 RNF19B RTN1 USP20 KMT2C FGFR1 ZNF579 TADA3 WNK2 ANK2 FHOD3 IRGQ CPT1A SPECC1 CELSR2 ADAMTS7 PDE4DIP SIX5 ASTN1 ST18 PLCE1

7.21e-0574723121Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K2
CoexpressionAtlasDevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_1000

RNF19B ZNF318 RB1CC1 KMT2C ANKRD12 HERC1 DOC2B DRP2 IRX3

1.56e-041792319gudmap_developingGonad_e14.5_ ovary_1000_k5
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000

NES SYCP2L EED MAP1B RTN1 SAP30 LUZP1 PPP1R2B RBM25 NEUROG1 ZNF579 WNK2 ADAMTSL1 ANK2 CAMSAP3 DYNC2I1 FHOD3 SPECC1 IWS1 LPIN3 CELSR2 FAM169A ASTN1 ST18

1.92e-0498323124Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlasfacebase_RNAseq_e10.5_NeuroEpith_central_2500_K4

NES BRPF3 MAP1B RRP1B CACNA2D2 SMARCAD1 ARMCX4 RTN1 SAP30 RBM25 BOD1L1 ZNF579 CFAP410 WNK2 HSP90AA1 TAF1D ANK2 ARID4A NSD2 DYNC2I1 FHOD3 IRGQ SIK3 VANGL2 CELSR2 ADAMTS7 CTCF FAM169A ASTN1 PLCE1

2.03e-04137023130facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
ToppCell(00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition

KIZ RB1CC1 LUZP1 BOD1L1 ANKRD12 HSP90AA1 TAF1D ARID4A DUSP6 AKAP12 IWS1 PHLDB2

7.94e-101992361219674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell(08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition

RB1CC1 TRIP12 LUZP1 BOD1L1 ANKRD12 CAVIN2 DYNC2I1 OAS1 IRX3 IWS1

3.58e-0913823610817e3f639604ea95adae01e8685ffaa2e0aff7a8
ToppCelldroplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PPP1R12A RB1CC1 LUZP1 TSC22D1 ANKRD12 HECTD1 CAVIN2 TAF1D WEE1 AKAP12 SENP6

7.76e-0919423611e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MAP1B DBNDD2 NACAD DLG2 ANK2 C1orf198 CELSR2 CLMN ST18 EPB41L1

1.17e-07199236105d2e85e40b6b52b1809e680b952913d77215b3d0
ToppCell10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MAP1B DBNDD2 NACAD DLG2 ANK2 C1orf198 CELSR2 CLMN ST18 EPB41L1

1.17e-07199236106fb5f931e6217142de38c1fffc011e63bda4772b
ToppCell(01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition

KIZ RB1CC1 RBM25 BOD1L1 ANKRD12 HSP90AA1 ARID4A DUSP6 SPECC1 AKAP12

1.17e-0719923610a2f7d0cabf35b80fe239fae34a77bf9344d5d743
ToppCell10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MAP1B DBNDD2 NACAD DLG2 ANK2 C1orf198 CELSR2 CLMN ST18 EPB41L1

1.17e-07199236109dd4b17fb8c70ab9e126b23b72600463f3db832d
ToppCell10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

MAP1B DBNDD2 NACAD DLG2 ANK2 C1orf198 CELSR2 CLMN ST18 EPB41L1

1.17e-07199236101bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

C8orf34 MET NECTIN4 KCNQ2 DNAH5 MLPH VEPH1 TMEM132D IRX2

6.36e-071842369102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7
ToppCellLA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper

OBSCN CMYA5 TSC22D1 SCN5A WNK2 PRUNE2 ANK2 PDE4DIP PLCE1

7.61e-0718823696d249fe92d51a19da19ec14bb2262d394255d577
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SMARCAD1 RB1CC1 NCBP3 RASA2 SPECC1 ZNF106 CTCF SENP6 STAG2

8.69e-07191236960c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SMARCAD1 RB1CC1 NCBP3 RASA2 SPECC1 ZNF106 CTCF SENP6 STAG2

8.69e-071912369973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCellcritical-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

NES MLPH ANO4 PRUNE2 ADAMTS1 VEPH1 CAVIN3 AKAP12 SNAI2

9.47e-0719323696be11fef87af04ee7a3cc223882ccd4077caded9
ToppCelldroplet-Mammary_Gland-nan-21m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DBNDD2 MET NECTIN4 MLPH IRX3 CELSR2 CLMN IRX2 CEP170B

9.89e-0719423690ef63abcfd057079a9a6f8b27404ff521d44845d
ToppCelldroplet-Mammary_Gland-nan-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DBNDD2 ARHGEF16 MET NECTIN4 MLPH IRX3 CELSR2 IRX2 CEP170B

1.08e-0619623699554ac6eb5f381bcde3ba40c32aa3fc340974540
ToppCelldroplet-Mammary_Gland-nan-18m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PIEZO1 DBNDD2 MET NECTIN4 MLPH IRX3 PPP1R2 CELSR2 CLMN

1.12e-061972369ed3a37f532741764060d297a560eeeeec279d9c4
ToppCell(04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition

RB1CC1 TRIP12 RBM25 BOD1L1 ANKRD12 CAVIN2 HSP90AA1 IWS1 STAG2

1.22e-06199236953ca3861f9e00dab3f3fbefb0837857ee39ab084
ToppCell367C-Epithelial_cells-Epithelial-B_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells)

CACNA2D2 PPP1R1B VEPH1 CAMSAP3 IRX3 RASEF IRX2 GPRIN2

3.29e-06168236816b517e3159ad6e6d25fd48f7d5f46e77b2b318d
ToppCell367C-Epithelial_cells-Epithelial-B_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells)

CACNA2D2 PPP1R1B VEPH1 CAMSAP3 IRX3 RASEF IRX2 GPRIN2

3.29e-061682368e20e1936573fdde78426d7a4eb45c458d5c4dbb4
ToppCellCOVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type

OBSCN CMYA5 SCN5A WNK2 ANK2 FHOD3 C4orf54 PDE4DIP

3.59e-0617023683f15242a1d3e4e9871d9170b2ef05842fb609c29
ToppCell3'_v3-GI_small-bowel-Mast-Mast_cell_granulo-myelo|GI_small-bowel / Manually curated celltypes from each tissue

RTN1 TSC22D1 CACNA1G MLPH CAVIN2 DUSP6 ADAMTS7 FAM169A

3.92e-0617223683df11aefc09762fd1f94441324551178e030b249
ToppCellEndothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id

CNTNAP3B MAP1B CNTNAP3 NACAD CAVIN2 DOC2B AKAP12 FAM169A

3.92e-061722368d4e98ff9c7cbc95457e1d71fa60f151a2f178dae
ToppCell5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TCEAL5 OBSCN DLG2 CACNA1G FGFR1 ANK2 ADAMTS1 AKAP12

4.84e-061772368bd602db857f37869ef76d14c05ef522c509f08ee
ToppCellCOVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

CNTNAP3B SYCP2L GAK FGD5 FGFR1 DUSP6 AKAP12 IL4R

5.48e-061802368493cf8d1a8f2a1ed2672f394a0338b110fd81d88
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CNTNAP3B CNTNAP3 MEIS3 C8orf34 ADAMTSL1 PCDH11Y VANGL2 IL4R

5.70e-06181236808f44323bf71b6004a921bbc969c954c75feeb66
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

CACNA2D2 C8orf34 MET DLG2 MLPH VEPH1 IRX3 MAP3K13

6.18e-0618323686847c1252d6bb105524f812658112517fd351eab
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9

PPP1R12A LUZP1 BOD1L1 ANKRD12 TAF1 ARID4A IWS1 CTCF

6.97e-06186236803db813598b67b1e08f759758a1c2023396921fa
ToppCellControl-Epithelial_cells|Control / group, cell type (main and fine annotations)

CACNA2D2 C8orf34 MET DNAH5 MLPH VEPH1 RASEF MAP3K13

7.53e-061882368707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCellILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

CMYA5 PRUNE2 SIN3B ANK2 ARID4A AKAP12 PPP1R2 EIF3B

8.14e-0619023689ce301841ce9486701fa28eb2a9929e35d476878
ToppCellRV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper

OBSCN CMYA5 SCN5A DLG2 WNK2 ANK2 FHOD3 PDE4DIP

8.14e-061902368fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCellPCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

MET NECTIN4 DNAH5 ADAMTSL1 IRX3 TMEM132D RASEF IRX2

8.46e-06191236860ff989fe99d243a3d52955223680cdd1f1917a4
ToppCellfacs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ARHGEF16 MET PPP1R1B MLPH IRX3 TMEM132D RASEF IRX2

8.46e-061912368c06bbad24e4897b2c3b5015e4de02411ebf75367
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RB1CC1 NCBP3 RASA2 SPECC1 ZNF106 CTCF SENP6 STAG2

8.46e-06191236809db184cb90fe282a14474d7217068c58092c6f8
ToppCellfacs-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ARHGEF16 MET PPP1R1B MLPH IRX3 TMEM132D RASEF IRX2

8.46e-0619123685f43f98cfe7a08d61ed55f34808fabfe47f1ac2e
ToppCellCOVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type

CNTNAP3B SYCP2L FGD5 FGFR1 CAVIN2 DUSP6 AKAP12 IL4R

8.46e-0619123682f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982
ToppCellEpithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor

C8orf34 MET ADAMTSL1 VEPH1 CELSR2 MAP3K13 ARHGEF2 IRX2

8.46e-061912368d3733c8c4bda70c4390e5601fdda6188a64be944
ToppCelldroplet-Lung-1m-Endothelial-venous_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

OBSCN TSC22D1 NYNRIN FGD5 CAVIN2 ADAMTS1 CAVIN3 SIX5

8.78e-0619223681990dc8a81594018a5bf596be99d0b5f0af0f58f
ToppCell3'-Child04-06-SmallIntestine-Epithelial-Tuft-related|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CMYA5 CLCN1 PPP1R1B B4GALNT4 CLMN FURIN BEST4 ST18

8.78e-061922368d6ea34391c3f730684b82e912d9cf55e928b3311
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor

CACNA2D2 C8orf34 MET DLG2 DNAH5 MLPH VEPH1 MAP3K13

8.78e-06192236806013a07e3a873b1d1c0451643c528593ac32a9c
ToppCelldroplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

OBSCN TSC22D1 NYNRIN FGD5 CAVIN2 ADAMTS1 CAVIN3 SIX5

8.78e-061922368845cc9c18b4436b07dd3ce7980052683937546d2
ToppCelldroplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

OBSCN TSC22D1 NYNRIN FGD5 CAVIN2 ADAMTS1 CAVIN3 SIX5

8.78e-061922368c72a082c93a8825adbfef37f889ba3a7052f201b
ToppCelldroplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DBNDD2 NECTIN4 MLPH IRX3 CELSR2 CLMN IRX2 CEP170B

9.12e-06193236822ebc3f586eb0aabc5785e468c88d7416c624ff4
ToppCellPCW_10-12-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

NECTIN4 DNAH5 ADAMTSL1 VEPH1 IRX3 TMEM132D RASEF IRX2

9.12e-061932368b25cdca3a1e381784ae48ca73c51cbb6ac62b811
ToppCellPCW_13-14-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

NECTIN4 DNAH5 ADAMTSL1 VEPH1 IRX3 TMEM132D RASEF IRX2

9.12e-061932368b38aaffbea36ef6c08ebe82675438f873c89b242
ToppCellnormal_Lung-Epithelial_cells-AT2|normal_Lung / Location, Cell class and cell subclass

CACNA2D2 MET TSC22D1 PPP1R1B MLPH VEPH1 IRX3 IRX2

9.12e-06193236880ad1bdc50ecb8a50362f718248441cae20904a6
ToppCellHippocampus-Neuronal|Hippocampus / BrainAtlas - Mouse McCarroll V32

MAP1B TCEAL5 RB1CC1 DLG2 ANKRD12 HERC1 FAM169A CEP170B

9.47e-0619423688aeb347b3024354c9505f4f0fddf0b843489dc6b
ToppCellPCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

MET NECTIN4 DNAH5 ADAMTSL1 IRX3 TMEM132D RASEF IRX2

9.47e-0619423686b286992d4bb56013c0ea5a7601d3476d806175a
ToppCellPCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

MET NECTIN4 DNAH5 ADAMTSL1 IRX3 TMEM132D RASEF IRX2

9.47e-061942368f95c8dc242c9aebcadfe61b1ed033349cb7e5a88
ToppCellCOVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type

OBSCN CMYA5 SCN5A DLG2 WNK2 ANK2 FHOD3 PDE4DIP

9.83e-06195236875fc81bddb246dca3b437fb60827b1d4fe416405
ToppCellTCGA-Thryoid-Primary_Tumor|TCGA-Thryoid / Sample_Type by Project: Shred V9

MET NECTIN4 MAP4K4 DUSP6 MAP3K6 NOL4L SMARCA4 CEP170B

9.83e-0619523687cdee2ae90edf15e4cbcf70797b8caf1f037b0ef
ToppCellTCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma|TCGA-Thryoid / Sample_Type by Project: Shred V9

MET NECTIN4 MAP4K4 DUSP6 MAP3K6 NOL4L SMARCA4 CEP170B

9.83e-061952368b61b8c931bd0ca3678486653ae1d7e9915c696c7
ToppCellnormal_Lung-Epithelial_cells|normal_Lung / Location, Cell class and cell subclass

CACNA2D2 MET TSC22D1 PPP1R1B MLPH VEPH1 IRX3 IRX2

9.83e-0619523687c90d887afde5c4d63352b5171be9987e2dfca58
ToppCellTCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9

DBNDD2 NACAD MET NYNRIN FGFR1 DOC2B IFFO1 ARHGEF2

9.83e-0619523685562665dd3beb70e2358aa32611a337bef5731c1
ToppCelldroplet-Lung-30m-Endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

NES FGD5 CAVIN2 ADAMTS1 CAVIN3 RGS12 AKAP12 PHLDB2

1.02e-05196236858871891185aa7e1e4ab9b99cd25c1ca3c932cc8
ToppCellMesenchymal_cells-Myofibroblasts|World / Lineage and Cell class

MAP1B ARL13B FGFR1 CAVIN2 DRP2 CLMN PAX7 CDH15

1.02e-0519623682c0f429ae18c2df05c33ddf58dcc2c94b819b9a1
ToppCellfacs-Diaphragm-Limb_Muscle-3m-Mesenchymal-skeletal_muscle_satellite_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RNF19B FGFR1 MAP4K4 DRP2 CLMN SNAI2 PAX7 CDH15

1.02e-05196236897ac47daf5bb07fa5dda3976e1ae402750f959b5
ToppCellsevere-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

CDK11A KMT2C RBM25 ANKRD12 HERC1 USP24 AKAP12 FAM169A

1.06e-05197236857ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TMEM169 MAP1B CLASP2 RTN1 DLG2 ANK2 FHOD3 ST18

1.06e-051972368fd43fc1cbf0c17b370397d73dddc572565a759c7
ToppCellH1299-infected-SARSCoV2|infected / Cell line, Condition and Strain

MAP1B RBM25 BOD1L1 ANKRD12 HSP90AA1 TAF1D ARID4A DYNC2I1

1.06e-0519723680fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCellFetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

MET NECTIN4 DNAH5 MLPH WNK2 ADAMTSL1 IRX3 RASEF

1.10e-0519823685fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d
ToppCell(11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition

RB1CC1 RBM25 BOD1L1 ANKRD12 DYNC2I1 SPECC1 IWS1 ZNF106

1.10e-05198236876d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCellFetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

MET NECTIN4 DNAH5 MLPH WNK2 ADAMTSL1 IRX3 RASEF

1.10e-0519823686ba5e5970109a04ed968bac7ff099ae250c579dc
ToppCell(09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition

RB1CC1 TRIP12 BOD1L1 ANKRD12 DNAH5 DYNC2I1 IWS1 STAG2

1.14e-051992368fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell(03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition

MAP1B RB1CC1 BBX BOD1L1 ANKRD12 SPECC1 ZNF106 STAG2

1.14e-051992368c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell3'-GW_trimst-1-SmallIntestine-Neuronal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TMEM169 MAP1B RTN1 SCN5A KCNQ2 DLG2 ANK2 DUSP6

1.14e-05199236886739a6f5e0fa7448389b97b3c4de41f2a7d7ebd
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

NEK1 NYNRIN PPP1R1B MLPH PRPH2 CAVIN3 SNAI2 PHLDB2

1.14e-051992368dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f
ToppCellEpithelial_cells|World / lung cells shred on cell class, cell subclass, sample id

CACNA2D2 MET TSC22D1 MLPH VEPH1 IRX3 RASEF IRX2

1.14e-051992368bbe69e44b7970f57628365ae771790f2b13d0cae
ToppCell(05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition

RB1CC1 LUZP1 RBM25 BOD1L1 ANKRD12 CAVIN2 HSP90AA1 STAG2

1.14e-051992368d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

NEK1 NYNRIN PPP1R1B MLPH PRPH2 CAVIN3 SNAI2 PHLDB2

1.14e-051992368c1760581c34b81d1d92c67500a1c8944e9cc6dad
ToppCellLung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

CACNA2D2 MET PPP1R1B MLPH VEPH1 IRX3 RASEF IRX2

1.18e-052002368acc771a902cf2f060c3eb9aedb72a256f5778a6c
ToppCellParenchyma_COVID-19-Epithelial-TX-AT2-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

CACNA2D2 MET PPP1R1B MLPH VEPH1 IRX3 RASEF IRX2

1.18e-052002368ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb
ToppCellBronchial-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

CACNA2D2 MET PPP1R1B MLPH VEPH1 IRX3 RASEF IRX2

1.18e-052002368b535323e18d9fb0dde1e0026df142c831e48c29f
ToppCellMS-IIF-Lymphocyte-T/NK-dn_T|IIF / Disease, condition lineage and cell class

LYST NACAD FGFR1 TCF7 USP24 IL23A SIX5 ZNF853

1.18e-052002368c34fff02992cba6bcc2308019cb00b94e1227300
ToppCell390C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

NES MAP1B PPP1R12A C8orf34 TSC22D1 PRUNE2 ADAMTS1 C1orf198

1.18e-0520023688b80a65b69b36ed405214564b939452c90aa40d6
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

DBNDD2 NACAD DLG2 ANO4 PRUNE2 C1orf198 CLMN ST18

1.18e-052002368829978708463a7459fe1041bd90196775bc4b531
ToppCell390C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)

NES MAP1B PPP1R12A C8orf34 TSC22D1 PRUNE2 ADAMTS1 C1orf198

1.18e-0520023682bc7f462a551292de2501028164573935232f899
ToppCellParenchymal-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

CACNA2D2 MET PPP1R1B MLPH VEPH1 IRX3 RASEF IRX2

1.18e-05200236823088edc62bf7d4db890937bfd7925dc316fcc76
ToppCellBiopsy_Other_PF-Epithelial|Biopsy_Other_PF / Sample group, Lineage and Cell type

CACNA2D2 MET DNAH5 MLPH VEPH1 IRX3 RASEF IRX2

1.18e-0520023681ef4d5ae698fa721e0f510bf0d918bd8d3b00591
ToppCellLung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CACNA2D2 MET PPP1R1B MLPH VEPH1 IRX3 RASEF IRX2

1.18e-052002368eb44d1f80ecaac3a022cd04ab16dc36151e45488
ToppCell368C-Lymphocytic-NK_cells-NK_cell_A|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

PAGE1 NES ZNF579 KIR3DL1 ADAMTS1 GOLGA8R ZNF853

2.09e-051572367542944030cd9b3f3559e64f9f6598694d74003c0
ToppCellPaneth_cell|World / shred on cell type and cluster

CNTNAP3B CACNA2D2 KCNQ2 FGFR1 PRUNE2 IFFO1 OFCC1

2.36e-051602367d787b7cdb8c3f677ac9c4934a5df9cc194df3987
ToppCellC_07|World / shred on cell type and cluster

CNTNAP3B CACNA2D2 KCNQ2 FGFR1 PRUNE2 IFFO1 OFCC1

2.36e-051602367b7c5a8a1c85da92e1945721b6887b32fad7b76b8
ToppCellRV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper

MAP1B PPP1R12A PRUNE2 SPECC1 AKAP12 CLMN PLCE1

2.46e-05161236747b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor

C8orf34 MET NECTIN4 DNAH5 MLPH VEPH1 CAMSAP3

2.66e-051632367e819a1d6d28290854aa0672b3a18fa9e293d8f23
ToppCellnormal_Lung-Epithelial_cells-Undetermined|normal_Lung / Location, Cell class and cell subclass

CACNA2D2 MET MLPH PGBD3 VEPH1 IRX3 IRX2

2.77e-051642367fa2dae15b38cb8f9642dbf00549beec8ee19e9bb
ToppCellCOVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type

MET PRUNE2 FHOD3 AKAP12 TMEM132D EPB41L1 PLCE1

3.23e-051682367a086c306be430adf0632ba53e98cd8014d2de330
ToppCellkidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

NES FGFR1 CAVIN2 VASH1 IRX3 MAP3K6 SNAI2

3.23e-05168236737249f38f8f04ec5743097259de67b106ca2b02f
ToppCell3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Tuft|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CMYA5 PPP1R1B B4GALNT4 ARHGEF10L CLMN FURIN ST18

3.35e-05169236705e12524d68d409fed386ffad233305683b4575b
ToppCellfacs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ARHGEF16 CACNA1G ADAMTSL1 ASTN1 EPB41L1 PPP1R12C PLCE1

4.03e-051742367197686570cec6d96a92e77e6409325d3bfe6f991
ToppCellfacs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ARHGEF16 CACNA1G ADAMTSL1 ASTN1 EPB41L1 PPP1R12C PLCE1

4.03e-0517423672eee7b5471672b439f95eba11494c2adf8cb7006
ToppCelldroplet-Kidney-nan-18m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BRPF3 ARMCX4 RTN1 NACAD ADAMTSL1 MAP3K6 CEP41

4.34e-051762367533d544852038c0612aacf87f4b1c88ff7aace82
ToppCellCOVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type

OBSCN CMYA5 SCN5A ANK2 FHOD3 C4orf54 PDE4DIP

4.34e-0517623679df7a124ebafb0087da0cda133a394275d7bed81
ToppCellwk_20-22-Hematologic-Myeloid-Promyelocyte-like|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

ERCC6L APOBR LYST CLCN1 IRGQ EIF3B CCDC144A

4.34e-051762367ee33d7077a92c1fd371081e7c990c7266e711957
ToppCelldroplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte-2|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RTN1 CACNA1G IRX3 AKAP12 FAM169A RASEF IRX2

4.50e-0517723678f0873d348f37c823294b698043319b6608b678a
ToppCelldroplet-Liver-LIVER_NPC-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAP1B FGFR1 CAVIN2 VASH1 AKAP12 LPIN3 ARHGEF10

4.83e-051792367025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCellfacs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAP1B PPP1R12A ADAMTSL1 IL23A ASTN1 EPB41L1 PLCE1

4.83e-0517923678da6863edc756540bb097cc7221c1408640d9bb4
ToppCellfacs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MAP1B PPP1R12A ADAMTSL1 IL23A ASTN1 EPB41L1 PLCE1

4.83e-051792367f39c13c99a07d009cc677e363ffe089089c64916
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CNTNAP3B CNTNAP3 MEIS3 C8orf34 ADAMTSL1 VANGL2 IL4R

4.83e-051792367f65889bf1e41396979cce44a5e63f49dea2bbd9b
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CNTNAP3B CNTNAP3 MEIS3 ADAMTSL1 PCDH11Y VANGL2 IL4R

5.00e-051802367b514c55e52b46e8a1a2f09ed2c59a7683367a505
ToppCellControl-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations)

CACNA2D2 C8orf34 DLG2 MLPH DUSP6 VEPH1 RASEF

5.00e-051802367198b19e7910b4a8cc7e820c525ab357c7f99f578
DrugMetaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; PC3; HT_HG-U133A

KMT2B RRP1B CACNA2D2 USP20 MET AP5Z1 AMFR ITCH KAT6A CPT1A RABL6 CTDP1

9.36e-07195235123669_DN
Druggeldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A_EA

KMT2B ZNF318 CXXC1 AP5Z1 DNMBP AMFR TCF7 WEE1 ARHGEF10 TRAPPC12 CLMN

5.07e-06191235111008_DN
DrugRapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A

KMT2B CLASP2 MET FGFR1 GOLGA3 TCF7 TCOF1 POLR2D ZBTB14 RABL6 ACIN1

6.18e-06195235116927_DN
DrugLoxapine succinate [27833-64-3]; Down 200; 9uM; MCF7; HT_HG-U133A

NES MYO9B GMIP ARHGEF16 MAP3K12 CXXC1 USP20 FGFR1 TCOF1 POLR2D PDIA4

6.49e-06196235115293_DN
DrugKarakoline [39089-30-0]; Down 200; 10.6uM; PC3; HT_HG-U133A

MAP3K12 FGFR1 TADA3 CFAP410 ATN1 ZBTB14 PDE4DIP CTDP1 CEP41 SNAPC4 EPB41L1

7.50e-06199235114297_DN
DrugLynestrenol [52-76-6]; Down 200; 14uM; PC3; HG-U133A

HLX RB1CC1 CXXC1 ANKRD12 TCF7 WEE1 MAP3K6 FURIN FAM169A STAG2 CEP170B

7.86e-06200235111953_DN
Drug(R)-(+)-Atenolol [56715-13-0]; Down 200; 15uM; MCF7; HT_HG-U133A

RNF19B ZNF318 LUZP1 MAP4K4 NSD2 KAT6A IRGQ RGS12 CTDP1 FAM169A SMARCA4

7.86e-06200235114841_DN
Drug17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A

CXXC1 SAP30 PARD6A SETMAR WEE1 NSD2 ZBTB14 ARHGEF10 SLF2 SNAPC4

2.85e-05189235105203_DN
DrugAmpyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A

MAP1B RNF19B MET FGFR1 TAF1 AMFR RASA2 KAT6A CPT1A PDE4DIP

2.98e-05190235104507_DN
Drug2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A

MAP1B MAP3K12 SAP30 MET BBX ATN1 RETREG2 PDE4DIP ARHGEF2 IL4R

3.12e-05191235101665_UP
DrugPF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A

MYO9B NACAD FGFR1 ATN1 USP24 ARHGEF10L ARHGEF10 PDE4DIP SENP6 MAP3K13

3.40e-05193235105922_UP
DrugPridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A

KMT2B MAP1B ZNF318 LUZP1 SBF1 ZBTB14 MZF1 CLMN SENP6 SNAPC4

3.56e-05194235107214_DN
DrugPiroxicam [36322-90-4]; Down 200; 12uM; HL60; HG-U133A

USP20 LUZP1 SBF1 TAF1 NSD2 IRGQ TRAPPC12 SEC23IP CTDP1 ARHGEF2

3.56e-05194235101405_DN
DrugHesperetin [520-33-2]; Down 200; 13.2uM; PC3; HG-U133A

RBM10 RB1CC1 LUZP1 NCBP3 ANKRD12 AMFR TCF7 WEE1 FURIN SEC23IP

3.56e-05194235101947_DN
DrugWY-14643; Up 200; 100uM; MCF7; HG-U133A

MYO9B RBM10 GMIP CXXC1 SBF1 AP5Z1 ANKRD12 NSD2 IRGQ TRAPPC12

3.72e-0519523510368_UP
DrugBumetanide [28395-03-1]; Down 200; 11uM; PC3; HT_HG-U133A

KMT2B MAP1B GMIP ARHGEF16 MET IRGQ MAP3K6 ARHGEF10 CTDP1 SMARCA4

3.72e-05195235105117_DN
DrugSecurinine [5610-40-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A

ARHGEF16 MAP3K12 PARD6A CFAP410 RETREG2 MZF1 CLMN PDE4DIP FAM169A CEP170B

3.72e-05195235103470_DN
DrugSulfaphenazole [526-08-9]; Down 200; 12.8uM; PC3; HT_HG-U133A

RRP1B GMIP ARHGEF16 MET PARD6A AP5Z1 FGFR1 HERC1 MAP3K6 EPB41L1

3.88e-05196235101794_DN
DrugSR-95639A [115767-94-7]; Down 200; 10uM; MCF7; HT_HG-U133A

EED ZNF318 LYST RBM25 SBF1 MAP4K4 AMFR SIK3 RGS12 IL4R

3.88e-05196235103272_DN
DrugParoxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A

KMT2B MYO9B PIEZO1 GMIP SBF1 FGFR1 KAT6A USP24 CTDP1 IL4R

4.05e-05197235104556_DN
DrugNadide [53-84-9]; Down 200; 6uM; MCF7; HT_HG-U133A

RRP1B RNF19B LYST MET SBF1 PARD6A FAM169A SENP6 SNAPC4 IL4R

4.05e-05197235107227_DN
DrugIopamidol [60166-93-0]; Down 200; 5.2uM; MCF7; HT_HG-U133A

MAP3K12 USP20 NEK1 TADA3 CFAP410 AMFR PDIA4 MZF1 CLMN CEP170B

4.05e-05197235103473_DN
DrugTrioxsalen [3902-71-4]; Down 200; 17.6uM; MCF7; HT_HG-U133A

MAP1B LEMD3 PARD6A DNMBP ITCH TCOF1 ARID4A SIK3 SEC23IP EPB41L1

4.05e-05197235106216_DN
DrugColistin sulfate [1264-72-8]; Down 200; 3uM; MCF7; HT_HG-U133A

RNF19B ZNF318 USP20 SBF1 AP5Z1 TCF7 ITCH ATN1 ARHGEF10L PDE4DIP

4.05e-05197235104796_DN
DrugLY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A

MYO9B PIEZO1 ARHGEF16 AP5Z1 ATN1 CELSR2 ADAMTS7 MZF1 PDE4DIP IL4R

4.23e-05198235106976_UP
Drugbutein; Down 200; 10uM; MCF7; HG-U133A

RBM10 MET ANKRD12 DRP2 ANK2 RGS12 PDE4DIP SEC23IP SMARCA4 ACIN1

4.23e-0519823510607_DN
DrugEthaverine hydrochloride [985-13-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A

MAP1B LYST CXXC1 USP20 LUZP1 NEK1 CPT1A RGS12 CLMN EPB41L1

4.41e-05199235105337_UP
DrugDelsoline [509-18-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A

KMT2B MAP3K12 PARD6A SIN3B ARHGEF10L SLF2 MZF1 PDE4DIP SNAPC4 IL4R

4.41e-05199235107212_DN
DrugCinnarizine [298-57-7]; Down 200; 10.8uM; PC3; HT_HG-U133A

MAP1B RRP1B SAP30 LUZP1 RABL6 MZF1 SEC23IP SENP6 SNAPC4 EPB41L1

4.41e-05199235105817_DN
Drugbromfenacoum

MAP1B LEMD3 PPP1R12A RTN1 LUZP1 NCBP3 TSC22D1 HECTD1 PICK1 CAMSAP3 ZC3H18 SIK3 SPECC1 ARHGEF10 CLMN FAM169A CEP170B EPB41L1

1.36e-0464423518ctd:C013418
Drug17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A

EED MAP1B RRP1B RNF19B LUZP1 RGS12 AKAP12 PDIA4 SENP6

1.53e-0418823596926_UP
DrugC768-0445; Up 200; 10uM; MCF7; HT_HG-U133A_EA

MAP3K12 AP5Z1 DNMBP TADA3 CFAP410 DUSP6 RGS12 SNAI2 SNAPC4

1.60e-041892359973_UP
DrugLuteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A

CLASP2 SAP30 MET NEK1 TAF1 TCF7 ZBTB14 CLMN SEC23IP

1.66e-0419023593379_DN
DrugGSK-3beta Inhibitor VIII; Up 200; 10uM; PC3; HT_HG-U133A

RRP1B RNF19B HLX DNMBP CFAP410 CPT1A ZBTB14 PDE4DIP SENP6

1.66e-0419023597070_UP
DrugGlimepiride [93479-97-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A

MYO9B LYST MET AP5Z1 KAT6A ARHGEF10L MZF1 SMARCA4 EPB41L1

1.87e-0419323594973_DN
DrugMexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A

ARHGEF16 MAP3K12 USP20 FGFR1 TADA3 ATN1 ZBTB14 FURIN SENP6

1.87e-0419323594338_DN
Drug17-AAG; Down 200; 1uM; MCF7; HG-U133A

KMT2B RBM10 FGFR1 TADA3 RETREG2 TCOF1 WEE1 NSD2 GPRIN2

1.94e-041942359428_DN
DrugMoroxidine hydrochloride [3160-91-6]; Down 200; 19.2uM; PC3; HT_HG-U133A

PPP1R12A MET FGFR1 TAF1 NSD2 KAT6A CTDP1 ARHGEF2 IL4R

1.94e-0419423596705_DN
Drug0173570-0000 [211245-44-2]; Down 200; 10uM; MCF7; HT_HG-U133A

MYO9B RNF19B TCF7 WEE1 KAT6A RGS12 ARHGEF10L TIGD6 PDE4DIP

2.02e-0419523594712_DN
DrugMecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A

MAP1B RRP1B MAP3K12 TAF1 CFAP410 TCF7 MZF1 FAM169A CEP170B

2.02e-0419523593525_DN
DrugBupivacaine hydrochloride [18010-40-7]; Up 200; 12.4uM; MCF7; HT_HG-U133A

RRP1B MAP3K12 SBF1 NYNRIN IRGQ MAP3K6 MZF1 SNAPC4 IL4R

2.02e-0419523597435_UP
Drugmonastrol; Up 200; 100uM; MCF7; HG-U133A

MYO9B GMIP MAP3K12 LUZP1 MAP3K6 ARHGEF10 TRAPPC12 MZF1 SNAPC4

2.02e-041952359311_UP
Drughaloperidol; Down 200; 10uM; HL60; HT_HG-U133A

RRP1B MYO9B DNMBP TCF7 KAT6A OAS1 MZF1 SEC23IP IL4R

2.02e-0419523596163_DN
DrugOxethazaine [126-27-2]; Down 200; 8.6uM; HL60; HG-U133A

SAP30 USP20 LUZP1 NEK1 SIN3B GPS1 IRGQ ARHGEF2 IL4R

2.02e-0419523591984_DN
Drugsodium bisulfite

PPP1R12A RB1CC1 NEUROG1 FGFR1 DUSP6 CAVIN3 CTCF MZF1

2.05e-041542358CID000024437
DrugGleevec; Up 200; 10uM; MCF7; HG-U133A

MYO9B RBM10 LUZP1 SBF1 AP5Z1 FGFR1 NSD2 TRAPPC12 MZF1

2.10e-041962359366_UP
DrugIsoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A

RBM10 PARD6A HERC1 DNMBP SIN3B SETMAR MAP3K6 MZF1 ACIN1

2.10e-0419623592056_DN
Drug1,1-dimethylbiguanide hydrochloride; Down 200; 10uM; MCF7; HG-U133A

CXXC1 RBM25 IFFO1 PRPH2 IRGQ ARHGEF10L SMARCA4 STAG2 EPB41L1

2.10e-0419623592_DN
DrugIoxaglic acid [59017-64-0]; Down 200; 3.2uM; MCF7; HT_HG-U133A

KMT2B RRP1B SAP30 PARD6A RASA2 RABL6 MZF1 SENP6 SNAPC4

2.10e-0419623597470_DN
DrugBrompheniramine maleate [980-71-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A

MYO9B PPP1R12A RNF19B LYST USP20 SBF1 FGFR1 ANKRD12 SEC23IP

2.10e-0419623593271_DN
DrugPramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; HL60; HT_HG-U133A

ERCC6L SBF1 DMP1 TADA3 TCF7 ITCH CPT1A ARHGEF10L CEP41

2.10e-0419623592198_DN
DrugIvermectin [70288-86-7]; Down 200; 4.6uM; PC3; HT_HG-U133A

RRP1B PPP1R12A CXXC1 SAP30 RBM25 ANKRD12 TCOF1 MZF1 SNAPC4

2.10e-0419623592051_DN
DrugHomatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A

PPP1R12A RNF19B LUZP1 AP5Z1 AMFR ATN1 MAP3K6 FURIN PDE4DIP

2.10e-0419623591684_DN
DrugHydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A

KMT2B MAP1B LUZP1 SBF1 FGFR1 CPT1A RGS12 MZF1 EPB41L1

2.10e-0419623592889_DN
DrugCAY10397; Up 200; 10uM; PC3; HT_HG-U133A

RNF19B HLX PARD6A NOC4L CFAP410 MZF1 FURIN PDE4DIP PLCE1

2.10e-0419623597071_UP
DrugZaprinast [37762-06-4]; Up 200; 14.8uM; MCF7; HT_HG-U133A

MAP1B ZNF318 LUZP1 TAF1 TCF7 OAS1 MZF1 PDE4DIP GPRIN2

2.18e-0419723595349_UP
DrugGlibenclamide [10238-21-8]; Down 200; 8uM; MCF7; HT_HG-U133A

KMT2B CLASP2 MAP3K12 MET PARD6A CPT1A MZF1 PDE4DIP POLI

2.18e-0419723597202_DN
DrugPropofol [2078-54-8]; Up 200; 22.4uM; HL60; HT_HG-U133A

DBNDD2 MET CFAP410 ANK2 OAS1 CPT1A RGS12 PDE4DIP PAX7

2.18e-0419723593048_UP
DrugFlunarizine dihydrochloride [30484-77-6]; Up 200; 8.4uM; MCF7; HT_HG-U133A

RNF19B MAP3K12 AP5Z1 TAF1 RGS12 MZF1 ARHGEF2 SNAPC4 IL4R

2.18e-0419723597412_UP
DrugFlavoxate hydrochloride [3717-88-2]; Down 200; 9.4uM; PC3; HT_HG-U133A

HLX ZNF318 MAP3K12 WEE1 POLR2D RABL6 CELSR2 SENP6 EPB41L1

2.18e-0419723596326_DN
DrugCinnarizine [298-57-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A

SAP30 SBF1 PARD6A FGFR1 AMFR RGS12 TIGD6 PDE4DIP ARHGEF2

2.18e-0419723597174_UP
DrugMetyrapone [54-36-4]; Down 200; 17.6uM; PC3; HT_HG-U133A

RRP1B ZNF318 SBF1 AP5Z1 ATN1 NSD2 IL23A MZF1 SMARCA4

2.18e-0419723594606_DN
DrugYohimbine hydrochloride [65-19-0]; Up 200; 10.2uM; HL60; HG-U133A

RBM10 LUZP1 PARD6A MLPH PDIA4 TRAPPC12 SEC23IP SNAPC4 GPRIN2

2.18e-0419723591763_UP
DrugMeglumine [6284-40-8]; Up 200; 20.4uM; MCF7; HT_HG-U133A

RBM10 RNF19B LYST TAF1 CFAP410 TCF7 OAS1 PDE4DIP SNAI2

2.18e-0419723595285_UP
DrugFolic acid [59-30-3]; Down 200; 9uM; MCF7; HT_HG-U133A

RNF19B CXXC1 FGFR1 ANKRD12 SIN3B VASH1 ARHGEF10L RABL6 SNAPC4

2.18e-0419723597201_DN
DrugVinpocetine [42971-09-5]; Down 200; 11.4uM; MCF7; HT_HG-U133A

ZNF318 CXXC1 NSD2 CPT1A SLF2 PDE4DIP SNAPC4 IL4R EPB41L1

2.18e-0419723597213_DN
DrugScoulerine [6451-73-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A

EED SBF1 WEE1 CPT1A RGS12 FURIN PDE4DIP SNAPC4 EPB41L1

2.18e-0419723595536_DN
Drugnovobiocin sodium, USP; Down 200; 100uM; PC3; HG-U133A

GAK CACNA2D2 RBM10 ZNF318 NSD2 DUSP6 OAS1 ZBTB14 TRAPPC12

2.18e-041972359435_DN
DrugDiethylcarbamazine citrate [1642-54-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A

MAP1B MYO9B USP20 NEK1 ATN1 KAT6A DYNC2I1 FURIN SNAI2

2.18e-0419723597425_DN
DrugMethantheline bromide [53-46-3]; Down 200; 9.6uM; PC3; HT_HG-U133A

RNF19B HLX GMIP ARHGEF16 MAP3K12 SBF1 AP5Z1 CELSR2 IL4R

2.18e-0419723595780_DN
Drug(-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; MCF7; HT_HG-U133A

CACNA2D2 RNF19B PARD6A FGFR1 TADA3 PDE4DIP ARHGEF2 SNAPC4 IL4R

2.18e-0419723592772_DN
Drug2-propylpentanoic acid; Down 200; 1000uM; ssMCF7; HG-U133A

RBM10 LUZP1 NOC4L DRP2 IFFO1 ZBTB14 SLF2 TRAPPC12 MZF1

2.18e-041972359497_DN
DrugKetoconazole [65277-42-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A

ARHGEF16 MAP3K12 CXXC1 TCF7 KAT6A FURIN PDE4DIP SENP6 SNAPC4

2.18e-0419723595685_DN
DrugAmidopyrine [58-15-1]; Down 200; 17.2uM; PC3; HT_HG-U133A

KMT2B PPP1R12A RNF19B MET SBF1 AMFR PDE4DIP CTDP1 IL4R

2.18e-0419723592060_DN
DrugArcaine sulfate [14923-17-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A

LYST MAP3K12 MET NEK1 SBF1 FGFR1 TIGD6 MZF1 CTDP1

2.18e-0419723594974_DN
DrugPyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A

RBM10 ZNF318 CXXC1 ANKRD12 DNMBP TCF7 DYNC2I1 MZF1 SNAPC4

2.18e-0419723597171_DN
DrugAdiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; MCF7; HT_HG-U133A

LYST NEK1 PARD6A TAF1 MZF1 FURIN PDE4DIP SNAI2 SENP6

2.18e-0419723597037_DN
DrugBromopride [4093-35-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A

LYST CLCN1 NYNRIN PRUNE2 ATN1 ANK2 DUSP6 PRPH2 RGS12

2.26e-0419823596037_UP
DrugLysergol [602-85-7]; Down 200; 15.8uM; MCF7; HT_HG-U133A

USP20 NEK1 SBF1 TADA3 SIK3 RGS12 SEC23IP SMARCA4 IL4R

2.26e-0419823593261_DN
DrugMecamylamine hydrochloride [826-39-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A

NES RRP1B ZNF318 MAP3K12 PARD6A FGFR1 ANKRD12 USP24 ZBTB14

2.26e-0419823597023_DN
DrugLactobionic acid [96-82-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A

RNF19B GMIP LYST NEK1 FGFR1 RGS12 RABL6 SNAI2 IL4R

2.26e-0419823593246_DN
DrugPinacidil [85371-64-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A

RRP1B MAP3K12 LUZP1 MET PARD6A ANKRD12 CFAP410 ATN1 ZBTB14

2.26e-0419823597437_UP
DrugDimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; MCF7; HT_HG-U133A

MYO9B ZNF318 ARHGEF16 SBF1 PARD6A WEE1 VASH1 ZBTB14 IL4R

2.26e-0419823594791_DN
DrugNitrofurantoin [67-20-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A

KMT2B RNF19B TAF1 CFAP410 ATN1 KAT6A RGS12 SLF2 GPRIN2

2.26e-0419823592303_DN
Drugnitrendipine; Down 200; 10uM; MCF7; HG-U133A

LYST USP20 LUZP1 ANKRD12 MAP3K6 AKAP12 TRAPPC12 PDE4DIP IL4R

2.26e-041982359336_DN
DrugBetazole hydrochloride; Down 200; 27uM; MCF7; HT_HG-U133A

EED MAP3K12 LUZP1 TCF7 VASH1 CPT1A MZF1 CLMN PDE4DIP

2.26e-0419823591690_DN
DrugNialamide [51-12-7]; Up 200; 13.4uM; PC3; HT_HG-U133A

RTN1 CACNA1G TADA3 PRUNE2 ATN1 IFFO1 RGS12 MAP3K13 SNAPC4

2.26e-0419823594525_UP
DrugAmiloride hydrochloride dihydrate [17440-83-4]; Up 200; 13.2uM; PC3; HG-U133A

MYO9B PIEZO1 TSC22D1 ANKRD12 WEE1 DUSP6 MZF1 SNAPC4 CEP170B

2.26e-0419823591890_UP
DrugDichlorphenamide [120-97-8]; Up 200; 13.2uM; MCF7; HT_HG-U133A

KMT2B LYST FGFR1 TAF1 TCF7 USP24 CELSR2 SLF2 PDE4DIP

2.35e-0419923595286_UP
DrugCefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; PC3; HT_HG-U133A

MAP1B RBM10 PARD6A AP5Z1 ANKRD12 GOLGA3 ARID4A CEP170B PLCE1

2.35e-0419923597148_DN
Drugsodium 4-phenylbutyrate; Up 200; 1000uM; MCF7; HG-U133A

LEMD3 RBM10 DBNDD2 CLASP2 SBF1 FGFR1 SETMAR DRP2 ARHGEF10

2.35e-041992359408_UP
DrugTubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; HL60; HG-U133A

GAK CLASP2 GMIP ANKRD12 NSD2 USP24 PDIA4 MZF1 SNAPC4

2.35e-0419923591738_DN
DrugMetanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; PC3; HG-U133A

RNF19B RB1CC1 NCBP3 ANKRD12 AMFR TRAPPC12 SEC23IP SMARCA4 EIF3B

2.35e-0419923591933_DN
DrugIsopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; PC3; HT_HG-U133A

HLX GMIP MAP3K12 MET FGFR1 KAT6A CPT1A IL4R EPB41L1

2.35e-0419923595879_DN
DrugFluorometholone [426-13-1]; Down 200; 10.6uM; MCF7; HT_HG-U133A

MYO9B FGFR1 TADA3 PICK1 PDIA4 MZF1 FAM169A ARHGEF2 GPRIN2

2.44e-0420023596071_DN
DrugPHA-00846566E [724718-26-7]; Down 200; 10uM; MCF7; HT_HG-U133A

MYO9B RNF19B LYST MAP3K12 RBM25 SBF1 NYNRIN MZF1 FURIN

2.44e-0420023597081_DN
DrugCiprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A

NES MYO9B RNF19B USP20 LUZP1 NEK1 FGFR1 GOLGA3 ARHGEF10L

2.44e-0420023595299_DN
DrugAmidopyrine [58-15-1]; Down 200; 17.2uM; HL60; HG-U133A

PPP1R12A USP20 NEK1 TSC22D1 ITCH RETREG2 WEE1 DUSP6 CTDP1

2.44e-0420023591376_DN
DrugCiprofloxacin hydrochloride [93107-08-5]; Up 200; 10.8uM; PC3; HG-U133A

ERCC6L MET TSC22D1 WEE1 AKAP12 ARHGEF10 SMARCA4 STAG2 GPRIN2

2.44e-0420023591939_UP
DiseaseIntellectual Disability

MAP1B PPP1R12A KMT2C ARL13B CACNA1G TAF1 ATN1 NSD2 RABL6 CTCF ACIN1 ASTN1 STAG2 EPB41L1

9.75e-0644722514C3714756
Diseasecataract 46 juvenile-onset (implicated_via_orthology)

LEMD3 LEMD2

5.79e-0522252DOID:0110243 (implicated_via_orthology)
Diseasetransforming growth factor-beta measurement

ZNF579 SBK3

5.79e-0522252EFO_0010799
DiseaseGrowth delay

NSD2 STAG2

1.73e-0432252C0456070
Diseasenon-alcoholic fatty liver disease, type 2 diabetes mellitus

C8orf34 DLG2 ADAMTSL1 SLF2 ST18 PHLDB2

2.04e-041102256EFO_0003095, MONDO_0005148
DiseaseMalignant neoplasm of breast

OBSCN ZNF318 RB1CC1 CLCN1 BOD1L1 FGD5 FGFR1 PGBD3 HSP90AA1 AMFR ANK2 ADAMTS1 NSD2 SIK3 CPT1A MAP3K6 AKAP12 TRAPPC12 SNAI2 MAP3K13

2.32e-04107422520C0006142
Diseasesortilin measurement

ATXN7L2 CELSR2

3.44e-0442252EFO_0600000
Diseasedimethylglycine measurement

ERCC5 PPP1R2P1 CACNA1G ADAMTSL1

4.18e-04462254EFO_0010476
Diseasestroke, coronary artery disease

CELSR2 ADAMTS7 SMARCA4

5.26e-04212253EFO_0000712, EFO_0001645
Diseasesick sinus syndrome (is_implicated_in)

SCN5A ANK2

5.70e-0452252DOID:13884 (is_implicated_in)
Diseasecholesterol to total lipids in very large VLDL percentage

SIK3 CPT1A CELSR2 SMARCA4

7.72e-04542254EFO_0022244
Diseasecholesterol:total lipids ratio, low density lipoprotein cholesterol measurement

AMFR SIK3 CPT1A ZNF106 CELSR2 SMARCA4

8.55e-041442256EFO_0004611, EFO_0020943
Diseaseobsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa

KIZ GMIP RTN1 GSDME FGFR1 L3MBTL2 FURIN

9.00e-042002257EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351
Diseasefree cholesterol to total lipids in medium VLDL percentage

SIK3 RGS12 CELSR2 SMARCA4

9.47e-04572254EFO_0022284
Diseaseresponse to perphenazine

FHOD3 C4orf54 CLMN

9.99e-04262253GO_0097334
Diseasebrain ischemia (biomarker_via_orthology)

NES SCN5A ADAMTS1 DUSP6 AKAP12

1.13e-031022255DOID:2316 (biomarker_via_orthology)
DiseaseAgents acting on the renin-angiotensin system use measurement

MYO9B HLX ZNF318 FGD5 INO80 RGS12 CELSR2 SMARCA4 PLCE1

1.15e-033352259EFO_0009931
Diseaselong QT syndrome (is_implicated_in)

SCN5A ANK2

1.19e-0372252DOID:2843 (is_implicated_in)
DiseaseSchizophrenia

PSD MYO9B RB1CC1 CMYA5 MET NEUROG1 PPP1R1B KCNQ2 DLG2 FGFR1 PICK1 RETREG2 GPS1 OFCC1 RGS12 CTCF

1.30e-0388322516C0036341
Diseasetriglycerides to total lipids in medium VLDL percentage

SIK3 RGS12 CELSR2 SMARCA4

1.38e-03632254EFO_0022335
Diseasecholesterol to total lipids in medium VLDL percentage

SIK3 RGS12 CELSR2 SMARCA4

1.38e-03632254EFO_0022239
Diseaselongevity, healthspan, parental longevity

NOL4L CELSR2 FURIN

1.38e-03292253EFO_0004300, EFO_0007796, EFO_0009762
Diseaseesterified cholesterol measurement, intermediate density lipoprotein measurement

CELSR2 SMARCA4

1.57e-0382252EFO_0008589, EFO_0008595
Diseaserestless legs syndrome (implicated_via_orthology)

MEIS3 MEIS3P2

1.57e-0382252DOID:0050425 (implicated_via_orthology)
Diseaseautosomal recessive intellectual developmental disorder (implicated_via_orthology)

CNTNAP3B CNTNAP3

1.57e-0382252DOID:0060308 (implicated_via_orthology)
DiseaseLeukemia, Megakaryoblastic, of Down Syndrome

CTCF STAG2

1.57e-0382252C1860789
DiseasePolydactyly

RBM10 NEK1 FGFR1 DYNC2I1 CEP41

2.07e-031172255C0152427
Diseasehypertension

MYO9B HLX ZNF318 FGD5 OAS1 FAM219B FURIN PLCE1

2.58e-033072258EFO_0000537
Diseaseintellectual disability (implicated_via_orthology)

BOD1L1 IRS4 ANK2 CAPN11

2.62e-03752254DOID:1059 (implicated_via_orthology)
Diseasecholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement

AMFR SIK3 CPT1A RGS12 CELSR2 SMARCA4 CDH15

2.73e-032432257EFO_0004612, EFO_0020944
DiseaseJeune thoracic dystrophy

CFAP410 DYNC2I1

3.04e-03112252C0265275
Diseasemean reticulocyte volume

MYO9B PIEZO1 ZNF318 NYNRIN TONSL RETREG2 RASA2 SPECC1 TIGD6 NOL4L SEC23IP POLI STAG2 CDH15

3.48e-0379922514EFO_0010701
DiseaseGlobal developmental delay

CACNA2D2 TAF1 ATN1 TRAPPC12 STAG2

3.60e-031332255C0557874
DiseaseEmery-Dreifuss muscular dystrophy (implicated_via_orthology)

LEMD3 LEMD2

3.63e-03122252DOID:11726 (implicated_via_orthology)
DiseaseCongenital small ears

LEMD3 TCOF1 SIX5

3.77e-03412253C0152423
Diseasefree cholesterol measurement, low density lipoprotein cholesterol measurement

NYNRIN USP24 CPT1A CELSR2 SMARCA4

4.08e-031372255EFO_0004611, EFO_0008591
DiseaseShort Rib-Polydactyly Syndrome

NEK1 DYNC2I1

4.27e-03132252C0036996
Diseasehereditary spastic paraplegia (implicated_via_orthology)

RTN1 CAPN11 SEC23IP

4.31e-03432253DOID:2476 (implicated_via_orthology)
Diseasefree cholesterol to total lipids in very small VLDL percentage

SIK3 CELSR2 SMARCA4

4.31e-03432253EFO_0022290
Diseaselung non-small cell carcinoma (is_implicated_in)

ERCC5 KMT2C FGFR1 NSD2 SMARCA4

4.34e-031392255DOID:3908 (is_implicated_in)
DiseaseAntihypertensive use measurement

MYO9B ZNF318 FGD5 INO80 FURIN PHLDB2 PLCE1

4.38e-032652257EFO_0009927
DiseaseSaldino-Noonan Syndrome

NEK1 DYNC2I1

4.96e-03142252C0036069
DiseaseMajewski Syndrome

NEK1 DYNC2I1

4.96e-03142252C0024507
Diseaseesterified cholesterol measurement, low density lipoprotein cholesterol measurement

CELSR2 SMARCA4

4.96e-03142252EFO_0004611, EFO_0008589
Diseasestroke

ANK2 C4orf54 ZNF106 FURIN SMARCA4

5.04e-031442255EFO_0000712
Diseaselipid measurement, lipoprotein measurement

NYNRIN SIK3 CELSR2 SMARCA4

5.04e-03902254EFO_0004529, EFO_0004732
Diseasevisual epilepsy (biomarker_via_orthology)

MAP1B FGFR1 ADAMTS1 DUSP6

5.04e-03902254DOID:11832 (biomarker_via_orthology)
Diseasesleep duration, low density lipoprotein cholesterol measurement

ATXN7L2 USP24 CELSR2 SMARCA4

5.24e-03912254EFO_0004611, EFO_0005271
Diseaseemphysema imaging measurement

ANKRD12 DNAH5 ADAMTSL1 WEE1 NSD2

5.34e-031462255EFO_0007626
Diseasecortical thickness

KMT2B SMARCAD1 ZNF318 LUZP1 FGFR1 WNK2 PICK1 SPECC1 VANGL2 ZNF106 NOL4L ADAMTS7 FURIN PAX7 SSH2 ST18 PLCE1

5.36e-03111322517EFO_0004840
Diseasecholesterol:total lipids ratio, high density lipoprotein cholesterol measurement

HLX SIK3 CPT1A RGS12 CELSR2 SMARCA4 CDH15

5.45e-032762257EFO_0004612, EFO_0020943
Diseasetotal lipids in small LDL

NYNRIN CELSR2 SMARCA4

5.54e-03472253EFO_0022168
DiseaseNeurodevelopmental Disorders

TRIP12 KMT2C KCNQ2 ANK2

5.66e-03932254C1535926
Diseaselung adenocarcinoma (is_implicated_in)

RBM10 KMT2C MAP4K4

6.23e-03492253DOID:3910 (is_implicated_in)
Diseasephospholipids in medium LDL measurement

NYNRIN CELSR2 SMARCA4

6.23e-03492253EFO_0022183
Diseasecholesterol in medium LDL measurement

NYNRIN CELSR2 SMARCA4

6.23e-03492253EFO_0022224
DiseaseCongenital total cataract

DNMBP LEMD2

6.47e-03162252C0266539
DiseaseRomano-Ward Syndrome

SCN5A ANK2

6.47e-03162252C0035828
Diseasepreeclampsia, hypertension, pregnancy-induced

FURIN PLCE1

6.47e-03162252EFO_0000668, MONDO_0024664
Diseasetriglycerides to total lipids in medium LDL percentage

SIK3 CELSR2 SMARCA4

6.59e-03502253EFO_0022334
Diseasetriglycerides to total lipids in large LDL percentage

SIK3 CELSR2 SMARCA4

6.96e-03512253EFO_0022331
Diseasephospholipids in very small VLDL measurement

SIK3 CELSR2 SMARCA4

6.96e-03512253EFO_0022300
Diseasecholesterol to total lipids in small VLDL percentage

SIK3 CELSR2 SMARCA4

6.96e-03512253EFO_0022242
Diseasefree cholesterol to total lipids in small HDL percentage

CPT1A CELSR2 SMARCA4

6.96e-03512253EFO_0022285
Diseaseprostate cancer (is_marker_for)

KMT2B KMT2C FGFR1 TCF7 SMARCA4

7.02e-031562255DOID:10283 (is_marker_for)
Diseaselow density lipoprotein cholesterol measurement, alcohol consumption measurement

GMIP NYNRIN CELSR2 SMARCA4

7.05e-03992254EFO_0004611, EFO_0007878
DiseaseMuscle hypotonia

NSD2 PAX7

7.30e-03172252C0026827
Diseasevery low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio

USP24 CPT1A RGS12 ZNF106 CELSR2 SMARCA4

7.32e-032222256EFO_0008317, EFO_0020943
Diseasephospholipids in medium VLDL measurement

SIK3 CELSR2 SMARCA4

7.35e-03522253EFO_0022154
Diseasetotal lipids in medium LDL

NYNRIN CELSR2 SMARCA4

7.35e-03522253EFO_0022180
Diseasetotal lipids in LDL measurement

NYNRIN CELSR2 SMARCA4

7.35e-03522253EFO_0022308
DiseaseMammary Neoplasms

RB1CC1 FGD5 FGFR1 HSP90AA1 ADAMTS1 NSD2 CPT1A AKAP12 CTCF SNAI2

7.54e-0352722510C1458155

Protein segments in the cluster

PeptideGeneStartEntry
GLLESEDRPAEDSED

TADA3

326

O75528
EPLLDNESTRGDERD

VANGL2

51

Q9ULK5
VSNDDRPEGSVEDEE

ACIN1

796

Q9UKV3
GDPEAAARIEEESAE

BEST4

451

Q8NFU0
GEGSDDSDSEKRRPE

CTDP1

866

Q9Y5B0
DFDSGDEIPEADRQA

ARHGEF10

56

O15013
DDEEDTSAALGVPSL

ARHGEF10L

41

Q9HCE6
SAAETGRDPLDSEEE

CFAP410

166

O43822
GRDPLDSEEEATSGA

CFAP410

171

O43822
DEGEPLVNADRRDSA

CNTNAP3

1231

Q9BZ76
RALENGDADEPSFSD

EIF3B

141

P55884
ILESSSSDDEDGPAE

ARID4A

271

P29374
DVGETEDDESPEQRA

BBX

66

Q8WY36
EVGESSDEEPVESRA

CAVIN3

161

Q969G5
KEDSSDSENAEPDLD

CTCF

606

P49711
DDPESEDVERGSKAS

CACNA2D2

171

Q9NY47
RAEAERPEEQAEASG

AKAP12

1071

Q02952
TEAPGELEASEEAAS

DUX4L4

391

P0CJ87
RLQDSSDPDTGSEEE

ARHGEF2

936

Q92974
PEETESRDGEAVASE

ARHGEF2

971

Q92974
PDENLVSLDSDSDGE

FAM219B

116

Q5XKK7
RALSDDGVSDLEDPT

GSDME

421

O60443
RSLNDDGSSDPRDID

ATN1

111

P54259
DDDILDESSSPEGTQ

ARHGEF16

231

Q5VV41
LPSDTESEGVEAEQE

C8orf34

501

Q49A92
LEDNDSAASDPDAET

CEP41

91

Q9BYV8
DETEEGYRSEDPDTS

CPT1A

421

P50416
VDEEPESSEVDAAGR

SPECC1

786

Q5M775
CSESEGERSPQQEEE

BRPF3

981

Q9ULD4
EDRSTEPDGSEAEGN

DNMBP

1501

Q6XZF7
EDETDRPSLESANGK

ARL13B

331

Q3SXY8
EGPGTLDTDDRSEQE

AP5Z1

256

O43299
EEEPLLDNSTRGTDV

CCDC144CP

266

Q8IYA2
PDTDSDSDLSLEDDQ

CELSR2

2716

Q9HCU4
ESSDTDNAEVEPVGR

DNHD1

231

Q96M86
RISDFENRSEPESDG

ANO4

831

Q32M45
NEERDSDTDSDPGHT

ANKRD12

71

Q6UB98
PEDALSGDSDVDTAS

CEP170B

946

Q9Y4F5
ESAESLDGSQEDKPR

CAPN11

11

Q9UMQ6
QPREASGEAEAEAEE

CAMSAP3

641

Q9P1Y5
NVGEDELSRESSPDI

ARMCX4

1881

Q5H9R4
ISKGNSPSDESEERE

ASTN1

896

O14525
RSRASSESELDDEGP

ATXN7L2

346

Q5T6C5
SEEPDLDLAGTGDRT

ADAMTS7

1081

Q9UKP4
SDSEEEQERGGPERE

RBM10

736

P98175
GNARPETVTNDDEEA

RBM25

181

P49756
TAEPEAGDQDSREVR

RASA2

21

Q15283
SDTDVPDIRDEETFG

RASEF

476

Q8IZ41
DDPDFESEGSDTQRR

RABL6

571

Q3YEC7
ESEGSDTQRRADDFP

RABL6

576

Q3YEC7
LGTPEEAESSEDEAG

RILP

306

Q96NA2
VSDALGRPSEEDEEL

ADAMTS1

46

Q9UHI8
ESEETRKLPGSDSEN

IWS1

121

Q96ST2
EPAGNRTVNSEDSDE

KIR2DS2

281

P43631
ISSDDSEDGLDDSNP

INO80

46

Q9ULG1
SLDQPSALEEARGDD

NOBOX

671

O60393
GNRLDEGSDVESEPD

PAX7

196

P23759
QSQDSTPAEEREDEG

PAGE1

36

O75459
TPAEEREDEGASAAQ

PAGE1

41

O75459
EPAGDRTVNREDSDD

KIR2DL5A

276

Q8N109
SDESDVEASPRDQAG

LEMD3

141

Q9Y2U8
RDPDGSAEDDSLEQT

ANK2

2511

Q01484
DTEGEELDVSRAESP

ANK2

2821

Q01484
ELPGESDRSAVETAD

RB1CC1

1416

Q8TDY2
PELDRDKSDSDTEGL

EPB41L1

641

Q9H4G0
SSPEELEAGAESELS

LPIN3

161

Q9BQK8
VEQEGADESTSGPED

MAP4K4

781

O95819
EPAGNRTVNSEDSDE

KIR2DS4

281

P43632
LQEDEEGFSRDSEAP

LRRC37A3

1611

O60309
EGFSRDSEAPTEEES

LRRC37A3

1616

O60309
GKSESSPEREAVDDE

KMT2C

1246

Q8NEZ4
SEATASDEENREDQP

MAP1B

1096

P46821
TSSAQGEAREDPLLD

GOLGA8T

581

H3BQL2
EQDERSPSRSEGEAE

HLX

361

Q14774
SRASEVPGAQDDEQE

NEUROG1

56

Q92886
DVADEDDNPSSESAL

NEK1

1146

Q96PY6
RGSSEEDEDARTPDR

LEMD2

136

Q8NC56
SSEAENEDREAGELP

L3MBTL2

51

Q969R5
AEPQLSGEESSSEDD

EIF1AD

126

Q8N9N8
GTESSDDFEERDPDL

GMIP

456

Q9P107
SSGEEDSDLSPEERE

PPP1R2P1

121

Q96PQ5
RSESDLSQPESDEEG

HERC1

1511

Q15751
DDDESSNEPESREKL

DYNC2I1

391

Q8WVS4
DSAERNTTSEEDPGA

ADAMTSL1

1046

Q8N6G6
DVRQDDGEDTLFSEP

C1orf198

291

Q9H425
EPAGDRTVNREDSDD

KIR2DL5B

276

Q8NHK3
RTANSEDSDEQDPEE

KIR3DL1

381

P43629
EAVSPRSEELSNEGD

MAP3K6

1126

O95382
NSEEASLPGEDIVDD

KCNQ2

506

O43526
ESTPEIAEQRGERDS

GPS1

226

Q13098
ADEPGTLEQVSRSEE

FGD5

151

Q6ZNL6
ASLTENEVSDSPGDE

NSD2

621

O96028
EDENRGDIPASISLS

VEPH1

466

Q14D04
RAPGAEEDDSELQRA

NCBP3

566

Q53F19
AEGASDTEREEPTES

PHRF1

911

Q9P1Y6
DTEREEPTESQGLAA

PHRF1

916

Q9P1Y6
SGSEEESDPVSLERE

NES

1496

P48681
TTGPRDDDESDDTLE

KCT2

156

Q8NC54
SPSSGGEDEDLDQER

MEIS3

246

Q99687
PDLSGDENDDAVSIE

EED

31

O75530
KAPRLDEDGEASEDT

KMT2B

2296

Q9UMN6
LAESNSADDETDDPR

OAS1

346

P00973
EEQQDSGSEPRGDED

DDX41

61

Q9UJV9
DDEGMQSDDPESIRS

DMP1

211

Q13316
ESDDSNSEIEAALRP

KIZ

646

Q2M2Z5
DLTVGRAPTADDDDD

NOL4L

151

Q96MY1
PDTDDRLENTSLAGD

GOLGA3

291

Q08378
SSGEEDSDLSPEERE

PPP1R2

121

P41236
EDEGDATRSKDESPD

IRX2

191

Q9BZI1
SSGGEDEDLDQEPRR

MEIS3P2

231

A8K0S8
EVGEAPSQEDERSAL

SBF1

711

O95248
AVEEDTSLSESEGPR

IFFO1

371

Q0D2I5
DSISELPEEDGRSQR

OBSCN

4756

Q5VST9
PQDESGREETLNSEA

OFCC1

136

Q8IZS5
PDSDDDSSDLVIENR

PARD6A

276

Q9NPB6
RPLQKSGDDSSEEEE

MAP3K13

806

O43283
KDETRVSTNGSDDPE

ITCH

211

Q96J02
LRGFSESSEEEEEPE

KAT6A

981

Q92794
EEEEEDEPSGATTRS

BOD1L1

2991

Q8NFC6
EDRDESEVSDEGGSP

GAK

821

O14976
ERDGNERDSSEPRDE

CXXC1

91

Q9P0U4
TLAGPSSDDENEEES

HECTD1

626

Q9ULT8
ASPESSRDDFQEGRE

IL4R

386

P24394
SPSDGAREDDEDVDQ

DOC2B

71

Q14184
DEEESSEEERASPAG

CACNA1G

1141

O43497
VNVSDALPSSEDDDD

FGFR1

116

P11362
SDDGADTPLAQSDEE

DBNDD2

231

Q9BQY9
DTPLAQSDEEEERGD

DBNDD2

236

Q9BQY9
ARLQDAEASEGPEDT

C7orf57

261

Q8NEG2
CPSDSEEDEGRGERT

FURIN

771

P09958
AESEEEPDSRLSDQD

CMYA5

41

Q8N3K9
TDDSPNVTDDAADEI

FHOD3

1351

Q2V2M9
LREEGDEETTNDVPH

IL23A

56

Q9NPF7
EEEPLLDNSTRGTDV

CCDC144B

316

Q3MJ40
SEELAEDPADGDKSR

DNAAF8

66

Q8IYS4
PESRFDRDSGESEEA

CDK11A

361

Q9UQ88
DEDNQRPLEDSATEG

C17orf50

36

Q8WW18
EPEQRGIEFEDESSD

FAM169A

386

Q9Y6X4
EELSSQPGDFSEEAE

LYST

1191

Q99698
GSTNTDERPDERSDD

MAP3K12

776

Q12852
SSGREKPDSDDDLDI

LUZP1

651

Q86V48
RPHEDLSEDNSSGEV

MARCHF11

381

A6NNE9
AEEVSSDSENIPEEG

KIAA1210

776

Q9ULL0
SEQETSDPERGQEDL

DLG2

651

Q15700
ASKQLEEEDGSRDSP

COPG1

236

Q9Y678
LGIDEDDPTADDTSA

HSP90AA1

696

P07900
TSSAQGEAREDPLLD

GOLGA8R

581

I6L899
EEEPLLDNSTRGTDV

CCDC144A

316

A2RUR9
GLERDLAPEDETSNS

GPRIN2

171

O60269
LTSEEAERSDGDPVQ

CAVIN2

401

O95810
PGDITSLTEEDDDNS

C4orf54

416

D6RIA3
ESDLDRDPNSATDSD

DUSP6

181

Q16828
HEGLTENREPDSVDE

POLI

686

Q9UNA4
DGDPEEDTATALQRL

SBK3

11

P0C264
ATDADDPETDNAALR

CDH15

176

P55291
GEEDPAQSRALESSL

NOC4L

421

Q9BVI4
EEAAEAPSLADGSTE

DRP2

811

Q13474
DEGEPLVNADRRDSA

CNTNAP3B

1231

Q96NU0
RDAPEAAGETSEEAD

DNAH5

2876

Q8TE73
PELISEERSGDSDQT

MLPH

151

Q9BV36
GDSERAAALSPEDET

IRGQ

406

Q8WZA9
EERLDDSSEAKGPED

ERCC6L

1111

Q2NKX8
VTELSDDADSGPLES

NYNRIN

971

Q9P2P1
DDVDSDGNRVTLDLP

PCDH11Y

926

Q9BZA8
SDSEDSSEGLEDRPL

IRX3

291

P78415
ENATAPVSDEESGDE

PGBD3

31

Q8N328
GSRSDSESEEEDLPV

IRS4

61

O14654
EPAGNRTVNSEDSDE

KIR2DS1

281

Q14954
ASSEEVSEERDDLGP

MROH2A

11

A6NES4
PSLLSSEDNADDEVD

MET

1366

P08581
SEDNADDEVDTRPAS

MET

1371

P08581
AESGDSEIELVSEDP

RTN1

406

Q16799
SEAGSEDEGEVSLPE

TIGD6

446

Q17RP2
DLESSDAQSDDVPDI

RNF19B

666

Q6ZMZ0
SDPRAGDVEEDASQL

POLR2D

6

O15514
DGDLSAEEIPENEVS

RRP1B

241

Q14684
QSAETIEEAGSPEDE

PRUNE2

2406

Q8WUY3
AEGEEAEPADRSQES

PPP1R12C

636

Q9BZL4
AEREEADSAIESQPS

PSD

306

A5PKW4
EEENAEGEVSRANTP

SMARCAD1

41

Q9H4L7
VSSRRPAGDSEEEED

TMEM132D

546

Q14C87
SDDDGGDSPVQDIDT

SAP30

131

O75446
EEESDSEEAAASPAQ

TCOF1

766

Q13428
PEEDEEELAAANSGR

NHSL2

86

Q5HYW2
LETDEEDSPSEGNSS

PLCE1

781

Q9P212
DDGSISPIEESTAED

TAF1D

201

Q9H5J8
DEEEEEQRSGPSVLS

TAF1

1831

P21675
GEAPAESESLLRDNS

ERCC5

691

P28715
SQEESPEGDTERTER

PRDM7

6

Q9NQW5
GGDEPLAETESESEA

RETREG2

271

Q8NC44
GSESPISDEEERLQS

SNAI2

101

O43623
QAGSGLSEEDAPERE

SCN5A

1931

Q14524
VAPRSDSEESGSEEE

SMARCA4

651

P51532
DDDNSLEGETFPLER

STRIP1

386

Q5VSL9
TEDESSRSPEDLERG

SIX5

276

Q8N196
GDESLEDEERSGRPS

SETMAR

396

Q53H47
EDEERSGRPSEVDND

SETMAR

401

Q53H47
LGASEESADEDRDSP

SIN3B

706

O75182
DGTLNLDSDEGEEPS

SIK3

441

Q9Y2K2
VAGAEGPDEDSSNRE

PDIA4

21

P13667
GPDEDSSNRENAIED

PDIA4

26

P13667
SLEGTDEEDPVTALE

WDR17

216

Q8IZU2
RATDLGEPERSSSEE

TSC22D1

161

Q15714
LLPGEDSTDVGEEDS

SEC23IP

51

Q9Y6Y8
DSDSESEDDGPTARD

SDAD1

231

Q9NVU7
SPIRIGEEDSTDDED

SLF2

701

Q8IX21
DEADLESLRQASGTP

PHLDB2

391

Q86SQ0
QEDRSDRTEDDGPLE

ST18

71

O60284
SSESREEEQAPEGRD

B4GALNT4

76

Q76KP1
EEGETSAQTERVPLD

AMFR

526

Q9UKV5
AEEAQEERGSSRDPV

APOBR

491

Q0VD83
ARPEEELTGEESEAA

APOBR

526

Q0VD83
APGSVQSSDDLEEDS

CLMN

881

Q96JQ2
QGPSLRSTDEEDEDE

CLCN1

971

P35523
DKSFDDEESVDGNRP

CLASP2

6

O75122
IGDQDDSPSDDTVEG

ZBTB14

166

O43829
EAQLDREGDAGPETS

TMEM128

21

Q5BJH2
RTSIPNAASEEGDED

WEE1

436

P30291
PLSENEDEGDSDGER

UTP14C

26

Q5TAP6
SGRSLNEELGDEDSE

RGS12

876

O14924
SEADSGEEECRSQPR

SSH2

21

Q76I76
EENETASEGSSPLAD

TRAPPC12

46

Q8WVT3
PLSGEEALTDRQESA

STAG2

506

Q8N3U4
SSGEEDSDLSPEERE

PPP1R2B

121

Q6NXS1
DGVSNPEESESESEG

PRPH2

291

P23942
EDETTDTQRGPRECE

TEX54

26

A0A1B0GVG6
SEGEDDTDGLTPQLE

TONSL

491

Q96HA7
DRESPSGLERETEQA

SYCP2L

426

Q5T4T6
EENGRAEETEADAPL

TRPC5OS

41

A6NMA1
RTEESDASQEGDDLP

TXNDC2

76

Q86VQ3
DRGTDDSPKDSQEDL

TCEAL5

121

Q5H9L2
PIILSSDDDDDNDRT

SENP6

331

Q9GZR1
EEQDDKSRDSAAGPE

TCF7

31

P36402
SDTDEKREGDRSPSE

USP20

266

Q9Y2K6
SGGSESQEEEEPQER

ZNF853

46

P0CG23
PQLRAASGEDSTEEA

WASHC2A

1081

Q641Q2
SLLSVDDDTDNPDDS

USP24

1716

Q9UPU5
SVPSRVGSESEDEDL

SNAPC4

1391

Q5SXM2
DDDERDVDASPTAGL

PIEZO1

156

Q92508
LSEDTDADRGSDPGT

WNK2

1261

Q9Y3S1
ESERDGGSEDQVEDP

PPP1R1B

171

Q9UD71
RSDNEKTDEEPGESE

TMEM169

56

Q96HH4
EDERESTDDESNPLG

TRIP12

1371

Q14669
LETSEGTSAQRDEEP

VASH1

31

Q7L8A9
GTSAQRDEEPEEEGE

VASH1

36

Q7L8A9
EEEDTAAGEPSRDTR

PICK1

386

Q9NRD5
PRESESEEAEAGAAE

ZNF579

191

Q8NAF0
GPEDRISVDSDGSDS

UHRF1BP1

1116

Q6BDS2
DETAPGVSESDRDQT

ZNF318

1516

Q5VUA4
TGREQESVRDEPDSD

ZNF106

1406

Q9H2Y7
SDLEDEESAARGPSQ

ZC3H18

46

Q86VM9
EESAARGPSQEEEDN

ZC3H18

51

Q86VM9
DEDSLEEDSPRALGS

NACAD

1351

O15069
ELDPRGSDEENLDSE

MYO9B

1986

Q13459
GRSENEAEREETTSP

PDE4DIP

1281

Q5VU43
NSEGDTPLDIAEEEA

PPP1R12A

136

O14974
ESEVTEDSDFLESGP

MZF1

186

P28698
DSAIPVESDTDDEGA

NMD3

461

Q96D46
VESDTDDEGAPRISL

NMD3

466

Q96D46
LSPGSGRAEEEEDQD

NECTIN4

461

Q96NY8